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ABSTRACT 
Lipoic acid is a covalently attached cofactor essential for the activity of  2-oxoacid 
dehydrogenases and the glycine cleavage system.  In the absence of lipoic acid modification the 
dehydrogenases are inactive and aerobic metabolism is blocked.  In Escherichia coli two 
pathways for the attachment of lipoic acid exist, a de novo biosynthetic pathway dependent on 
the activities of the LipB and LipA proteins and a lipoic acid scavenging pathway catalyzed by 
the LplA protein.  LipB is responsible for octanoylation of the E2 components of 2-oxoacid 
dehydrogenases to provide the substrates of LipA, a SAM radical enzyme that inserts two sulfur 
atoms into the octanoyl moiety to give the active lipoylated dehydrogenase complexes.  We 
report that the intact pyruvate and 2-oxoglutarate dehydrogenase complexes specifically 
copurify with both LipB and LipA.  Proteomic, genetic and dehydrogenase activity data indicate 
that all of the 2-oxoacid dehydrogenase components are present.  In contrast LplA, the lipoate 
protein ligase enzyme of lipoate salvage, shows no interaction with the 2-oxoacid 
dehydrogenases. The interaction is specific to the dehydrogenases in that the third lipoic acid 
requiring enzyme of E. coli, the glycine cleavage system H protein, does not copurify with 
either LipA or LipB. Studies of LipB interaction with engineered variants of the E2 subunit of 
2-oxoglutarate dehydrogenase indicate that binding sites for LipB reside both in the lipoyl 
domain and catalytic core sequences.  We also report that LipB forms a very tight, albeit 
noncovalent, complex with acyl carrier protein.  These results indicate that lipoic acid is not 
only assembled on the dehydrogenase lipoyl domains, but that the enzymes that catalyze the 
assembly are also present “on site”.  
We have also investigated a possible alternative route for lipoic acid biosynthesis in which 
Lipoic acid is synthesized on ACP and transferred by LipB to unmodified lipoyl domains. Since 
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LipB was demonstrated to proceed through an acyl-enzyme intermediate, we attempted to 
isolate an acylated peptide from LipB, and isolated the unmodified peptide containing the active 
site cysteine C169. However no acylated peptide was found. We demonstrate biochemically that 
the octanoylated peptide is cleaved in the trypsin digestion reaction possibly by attack by the 
two other cysteine residues (C137 and C147). Chemical transfer of octanoyl from octanoyl-
imidazole to the peptide was also unsuccessful suggesting an intrinsic instability of the peptidyl 
thioester bond. Consequently we resorted to study the intact LipB proteins by total hydrolysis 
and GC/MS and found that the enzyme-bound acyl intermediate is octanoic acid rather than 
lipoic acid. Octanoyl-ACP was not a substrate for LipA in vivo thus providing further evidence 
that LipB is an Octanoyl-[Acyl Carrier Protein]:Protein N-Octanoyltransferase and not a Lipoyl 
transferase in vivo. 
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CHAPTER ONE: INTRODUCTION 
 
1.1 Lipoic Acid as a cofactor 
Lipoic acid is a sulfur-containing cofactor derived from octanoic acid found in most prokaryotic 
and eukaryotic organisms (Fig. 1.1). It is essential for the function of several key enzymes 
involved in oxidative and single carbon metabolism including pyruvate dehydrogenase (PDH), 
2-oxoglutarate dehydrogenase (2-OGDH), branched-chain 2-oxoacid dehydrogenase, acetoin 
dehydrogenase and the glycine cleavage system. In each enzyme, a specific subunit is modified 
by the attachment of lipoic acid to a specific lysine residue within conserved domains called 
lipoyl domains (LD). In each of these domains a lipoamide linkage is formed between the 
carboxyl group of lipoic acid and the ε-amino group of the lysine residue (Fig. 1.1). During 
catalysis, the protein-bound lipoamide serve as a carrier of reaction intermediates among the 
multiple active sites of the complexes. 
 
1.2 Lipoic Acid dependent multienzyme complexes: 
1.2.1 The 2-Oxoacid dehydrogenase complexes: PDH and OGDH 
The reaction mechanism of the pyruvate dehydrogenase complexe (PDH) is the most studied 
lipoic acid-dependent enzyme (Fig. 1.2). PDH catalyzes the oxidative decarboxylation of 
pyruvate to acetyl-CoA. This very large enzyme complex, larger than the ribosome, can be 
observed as large particles on electron micrographs (1). It consists of multiple copies of each of 
three subunits encoded by the aceE aceF lpd operon. The first subunit (encoded by aceE) is a 
thiamine pyrophosphate-dependent decarboxylase (E1p) that catalyzes the decarboxylation of 
pyruvate and the reductive acetylation of the lipoyl group that is covalently attached to the 
second subunit, E2p ( encoded by aceF). The E2p subunit is a dihydrolipoyl acetyltransferase 
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responsible for the transfer of the acyl group from lipoyl moiety to CoA to form acetyl-CoA. 
The third subunit, E3 (encoded by lpd), is a dihydrolipoyl dehydrogenase that serves to 
regenerate the disulfide bond of the lipoyl moiety of E2p and therfore prepare the enzyme for 
another cycle of catalysis (Fig. 1.2). The E2p subunit to which E1p and E3 are bound strongly 
but noncovalently forms the structural core of the complex.  
The reaction mechanism of 2-OGDH is similar to that of PDH (Fig. 1.2) and the two complexes 
have similar architechture: The 2-OGDH complex contains three subunits, a 2-oxoglutarate 
decarboxylase component E1o (encoded by sucA), a trans-succinylase component E2o (encoded 
by sucB) and the same dihydrolipoyl dehydrogenase E3 as the PDH. The 2-OGDH complex 
catalyzes a key step in the citric acid cycle and also supplies 
succinyl-CoA for the biosynthesis of methionine and lysine (2). 
In all 2-oxoacid dehydrogenase complexes, the core of the structure is provided by the E2 
subunits to which the E1 and E3 components are bound noncovalently to a peripheral subunit 
binding domain (Fig. 1.3). The E2 components are organized into either octahedral or 
icosahedral symmetries depending on the organism (24-mer octahedral symmetry in gram 
negative bacteria; 60-mer icosahedral symmetry in gram positive bacteria and mitochondria). In 
all 2-oxoacid dehydrogenase complexes, the E2 component has a multidomain structure 
comprising, from the N-terminus: a lipoyl domains region, a small peripheral subunit-binding 
domain and a catalytic domain that contains the acyltransferase activity near its C-terminus and 
aggregates to form the inner core of the complexes. The lipoyl domains are separated by 
extended segments (25–30 residue) of alanine, proline and charged amino acids rich regions that 
form flexible but extended linkers (3). The lipoyl moiety that is attached to the tip of the 
protruding β-turn of the lipoyl domain, together with the domains themselves plus the linker 
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regions connecting the multiple lipoyl domains and the catalytic domain, make long swinging 
arms that are able to carry the reaction intermediates to the distant E1 and E3 active sites (4). 
Deletion of the linker region in a single lipoyl domain E2p chain caused an almost total loss of 
overall activity (5).  
The numbers of lipoyl domains in PDH complexes usually varies between one and three per E2 
subunit depending on the organism. However, all of the 2-OGDH E2o subunits described to 
date contain a single lipoyl domain, which is also the case for the E2b chains of all branched 
chain dehydrogenase complexes (6, 7).  
There is no straight forward explanation for the variation in the number of lipoyl domains. In E. 
coli PDH, selective deletion of one or two lipoyl domains has no effect on the overall catalytic 
activity (8). Studies using multi Lip-PDH complexes bearing one N-terminal lipoyl domain and 
up to seven unlipoylated (mutant) domains per E2p chain, were conducted. Their catalytic 
activities declined significantly as the number of unlipoylated domains increased above four per 
E2p chain. It was concluded that the extra domains protrude from the 24-meric E2p core 
without affecting assembly of the E1p and E3 subunits, and that the lipoyl cofactor bound to the 
outermost domain can participate successfully at each of the three types of active site in the 
assembled complex. Three lipoyl domains per E2p chain is optimal and only the outermost 
domain need be lipoylated for optimal activity. It is concluded that the reason for retaining three 
lipoyl domains is to extend the reach of the outermost lipoyl cofactor rather than to provide 
extra cofactors for catalysis (9). 
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1.2.2 A related complex: The glycine cleavage system   
The third lipoylated protein of E. coli is the H protein of the glycine cleavage system, an 
enzyme widely distributed in bacteria and in the mitochondria of plants, fungi and mammals 
(10). The glycine cleavage system catalyzes the reversible cleavage of glycine, yielding carbon 
dioxide, ammonia, 5,10-methylenetetrahydrofolate plus a reduced pyridine nucleotide. In 
contrast to the 2-oxoacid dehydrogenases, it consists of four proteins T, H, P and L and it is 
encoded by the gcvT gcvH gcvP operon while L protein is common to the 
2-oxoacid dehydrogenases. P protein catalyzes the pyridoxal phosphate dependent 
decarboxylation of glycine and transfers the methylamine group to the lipoyl prosthetic group 
on the H protein. T protein catalyzes the release of ammonia and transfer of methylene  
group to tetrahydrofolate. L protein catalyzes the reoxidation of the dihydrolipoyl residue of H 
protein and reduction of NAD
+
. Thus, the lipoic acid moiety of H protein interacts with the 
active sites of three different enzymes analogous to that found for 2-oxoacid dehydrogenase 
complexes. In contrast to the 2-oxoacid dehydrogenases, the subunits of the glycine cleavage 
system are loosely associated (10) this is mainly due to the fact that the lipoylated H protein is a 
relatively small protein and thus it does not form the complex core structures associated with 2-
oxoacid dehydrogenases.  
 
1.2.3 Other lipoylated complexes absent from E.coli 
Another lipoate-dependent enzyme complex is the branched-chain ketoacid dehydrogenase 
(BCDH). It has three subunits, E1b, E2b and E3, and catalyzes the oxidative decarboxylation of 
branched-chain α–ketoacids, generating branched-chain acyl-CoAs, similar to the reaction of  
the PDH and OGDH (6). The substrates of BCDH, branched-chain α–ketoacids, are usually the 
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transamination products of the branched-chain amino acids valine, leucine and isoleucine. 
BCDH serves a number of metabolic functions, including branched-chain fatty acid 
biosynthesis in B. subtilis (11), cell-cell signaling in Myxococcus xanthus (12), and biosynthesis 
of the antibiotic avermectin in Streptomyces avermitilis (13).  
Acetoin dehydrogenase is another lipoate-dependent enzyme complex. Acetoin dehydrogenase 
catalyzes the oxidative cleavage of acetoin to acetyl-CoA and acetaldehyde. The three subunits 
of this enzyme complex resemble those of the PDH and KGDH.  
Protein X is another lipoylated protein found as a minor component of the mammalian and yeast 
PDHs (14) (15). Protein X has been proposed to function as the protein that binds and positions 
E3 subunit to the E2 core, maintaining the structure of the PDH complexes (16, 17).  
 
1.3 Lipoyl Domains and Biotinyl Domains 
Subgenes that encode the lipoyl domains from various sources have been cloned and 
overexpressed in E. coli and their three-dimensional structures solved, including a hybrid lipoyl 
domain (outermost with innermost) commonly used in biochemical assays (18), the single 
lipoyl domains of E. coli E2o (19) and the H protein from pea leaves (20). All of these 
structures share stricking similarities with each other and with the biotinyl domains, their 
structures are shown in Figure 1.4. The structure is composed largely of two four-stranded β-
sheets, and the lysine residue subject for lipoylation or biotinylation is in an exposed position in 
a tight type I β-turn generated by β-strand 4 and 5 in the other sheet. 
Both the lipoyl domain and biotinyl domain contain a three-amino acid motif including the 
specific lysine at the tip of the β-turn, DKA in the lipoyl domain and MKM in the biotinyl 
domain. Site-directed mutagenesis of either the lipoyl domain or the biotinyl domain by moving 
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the conserved lysine to the adjacent positions abolished the corresponding modifications and 
changing the flanking residue to lysine did not result in double modification (but did lower the 
rate of biotinylation), indicating that precise positioning of the lysine residue is absolutely 
required for the correct modification (21) (22). Replacing the MKM motif in the biotinyl 
domain with DKA generated a mutant domain that was the target of lipoylation, but not 
biotinylation (22) whereas replacing the DKA motif in the lipoyl domain with MKM did not 
change the domain’s ability to be lipoylated (21). All lipoyl domain mutants reported with 
substitutions in the flanking asparate or alanine virtually did not affect the domains’ abilities to 
be lipoylated (but affect the reductive acetylation of the mutant domains by E1 component), 
suggesting the flanking region around the lipoyl-lysine is not necessary for lipoylation (21). 
 
1.4 Lipoic acid biosynthesis and attachment pathways 
In E. coli, two complementary systems for protein lipoylation have been discovered. Exogenous 
lipoate or octanoate is transferred to unlipoylated apoproteins in an ATP-dependent manner by 
LplA (23). The second E. coli pathway requires the lipB gene product (octanoyl-acyl carrier 
protein (ACP):protein-N-octanoyltransferase) to transfer endogenously synthesized octanoate 
from fatty acids synthesis to apoproteins which then become substrate for sulfur insertion (23-
25) (Fig. 1.5). 
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1.4.1 Lipoate-protein ligase (LplA) of the scavenging pathway 
Lipoate-protein ligase activity was initially observed in the early studies of lipoic acid 
metabolism in E. faecalis (26, 27). A lipoate-activating enzyme activity was described to 
activate apo-PDH in the presence of lipoate, ATP and a divalent metal ion such as Mg
++
. These 
studies postulated that lipoate was attached to protein by a two-step ATP dependent reaction 
with lipoyl-AMP as an activated intermediate. A single gene, lplA, responsible for the ATP-
dependent lipoate-protein attachment was identified in E. coli (23). The lplA gene is located at 
99.6 min of the E. coli chromosome and encodes a 38kDa monomeric protein. The protein has 
been cloned and overexpressed (23, 28). LplA catalyzes the two-step ATP dependent reaction to 
lipoylate proteins. In the first step, lipoyl-AMP is generated as an intermediate, and in the 
second step the lipoyl group is transferred from lipoyl-AMP to the ε–amino group of the 
conserved lysine on the target protein. Assays with a fully purified apoprotein acceptor have 
demonstrated that purified LplA plus lipoate and Mg-ATP are sufficient to reconstitute 
lipoylation in vitro. 
In mammals, lplA equivalents have been reported. In contrast to E.coli where a single gene 
product LplA is responsible for the two-step ATP-dependent lipoylation, mammals require two 
independent enzymes for this modification. Lipoyl-AMP:N-ε-lysine lipoylatransferase has been 
identified from bovine liver mitochondria (29, 30) and human (31). This enzyme catalyzes the 
transfer of the lipoyl group from lipoyl-AMP to the conserved lysine and has been shown to be 
able to lipoylate the H protein of the glycine cleavage system (30) and the E2 component of 
mammalian PDH, OGDH and BCDH (32) in the presence of lipoyl-AMP. On the other hand, 
the enzyme that catalyzes the initial lipoate activation in the presence of ATP was described 
earlier (33) and the encoding cDNA has been reported recently (34). Biotin-protein ligase 
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(BirA) catalyzes a two-step ATP-dependent biotinylation reaction that is strikingly similar to 
that of LplA. Again, biotin is activated in the presence of ATP, generating biotinyl-AMP as the 
enzyme-bound intermediate. The biotin moiety is then transferred from biotinyl-AMP to the ε–
amino group of the conserved lysine on the biotin-dependent proteins. The BirA has three 
distinct domains: the N-terminal domain is a DNA binding domain with a helix-turn-helix 
motif; the central domain is the catalytic domain; the C-terminal domain has an unknown 
function. BirA is a dual-function protein that is involved in both the attachement and the 
regulation of biotin biosynthesis.  
A number of crystal structures of LplA proteins have emerged, including structures of E. coli 
LplA plus an LplA-lipoic acid complex (35). The structures show E. coli LplA to be a two-
domain protein consisting of a large N-terminal domain and a small C-terminal domain. An 
LplA homologue from Thermoplasma acidophilum was crystallized. Addition of lipoic acid to a 
complex of the T. acidophilum with ATP gave a lipoyl-AMP intermediate bound in a U-shaped 
pocket and was well shielded from solvent (36).  Recently, two new E. coli LplA structures 
were reported: LplA.lipoyl-5'-AMP and LplA.octyl-5'-AMP.apoH-protein complexes, which 
represent the post-lipoate adenylation intermediate state and the pre-lipoate transfer 
intermediate state, respectively. These structures demonstrate three large scale conformational 
changes upon completion of the lipoate adenylation reaction: movements of the adenylate-
binding and lipoate-binding loops to maintain the lipoyl-5'-AMP reaction intermediate and 
rotation of the C-terminal domain by about 180 degrees (37). 
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1.4.2 Octanoyl-ACP:Protein N-Octanoyltransferase (LipB) of the biosynthesis pathway 
During the characterization of E. coli lplA null mutant strains, compelling evidence was found 
for a second protein lipoylation pathway that did not require the lplA gene product and lplA null 
mutants were found to contain normal levels of lipoylated proteins (38). Thus, it was clear that 
E. coli has an lplA-independent lipoylation pathway. The alternative protein lipoylation pathway 
was depended on the lipB gene product. Genetic and biochemical evidence demonstrated that 
lipB encoded the octanoyl(lipoyl)-ACP:protein N-octanoyltransferase. Thus when presented 
with free lipoic acid in the medium, E. coli incorporates extracellular lipoate via the LplA and 
ATP dependent scavenging pathway. When lipoate is absent from the medium, lipoyl groups 
must be made by de novo synthesis. An octanoyl group is first transferred from octanoyl-ACP 
to the apo-proteins by LipB. LipA then acts on the protein-bound octanoyl groups to catalyze 
the sulfur insertion step (39).  
The LipB reaction was shown to proceed via an acyl enzyme intermediate (40). The octanoyl 
group is transferred from the ACP thiol to the thiol of Cys-169. This protein-bound thioester is 
then attacked by the ε-amino group of the lipoyl domain lysine to give the modified domain 
according to the following reactions: 
 
Octanoyl-ACP + LipB ↔ [Octanoyl-LipB] + ACP-SH 
[Octanoyl-LipB] + Apo-lipoyl domain → Octanoyl-E2 domain 
 
LipB from M. tuberculosis was crystallized and the crystal structure contained an unusual 
linkage to a decanoyl group through a thioether linkage to C-3 of decanoate rather than a 
thioester link to the carboxyl group (41). This unexpected linkage was the result of a Michaels 
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addition of the cysteine thiol to the unsaturated bond of trans-2 decenoyl-ACP or cis-3-
decenoyl-ACP, a key intermediate in E. coli unsaturated fatty acid biosynthesis. No adduct was 
obtained when the protein was expressed in Mycobacterium smegmatis, which forms 
unsaturated fatty acids by a pathway that does not involve decenoyl intermediates (41). LipB is 
thought to function as a novel cysteine/lysine dyad acyltranferase, in which the dyad residues 
function as acid/base catalysts (41). 
 
1.4.3 Lipoyl Synthase (LipA) of the biosynthesis pathway 
Octanoic is the established precursor of the lipoic acid carbon chain (42). Sulfur atoms are 
introduced with loss of only two hydrogen atoms from C-6 and C-8 (43, 44). Additional studies 
demonstrated that E. coli lipoic acid biosynthesis does not involve either desaturation or 
hydroxylation of octanoic acid but does result in inversion of stereochemistry at C-6 (44, 45) 
and racemization at C-8 in agreement with the formation of an intermediate carbon radical at C-
8 (43, 46-48).  
LipA encodes a protein called lipoic acid synthase. There are strong parallels between LipA and 
the biotin synthase (BioB), the enzyme that catalyzes the final step in biotin biosynthesis (Fig. 
1.6). LipA-like BioB makes two C–S bonds and also removes two unactivated hydrogen atoms. 
BioB has both a [4Fe-4S] cluster and a [2Fe-2S] cluster. These enzymes use S-adenosyl-L-
methionine (SAM) as the source of a 5’-deoxyadenosyl radical (5’-dA•). The reaction requires 
the input of one electron, which is supplied by a [4Fe-4S] cluster that is housed in a 
CXXXCXXC motif common to all Radical SAM enzymes. The canonical iron-sulfur cluster 
binding motif CXXXCXXC is also found in the LipA sequence. LipA was reported to contain 
two distinct [4Fe-4S] clusters per polypeptide (49). LipA also contains a CXXXXCXXXXXC 
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motif which is unique to lipoic acid synthases and postulated to contain the second [4Fe-4S] 
cluster responsible for sulfur insertion. 
The role of the 5’-dA• is to remove a key hydrogen atom from the substrate, which initiates the 
catalytic cascade. In LipA, the 5’-dA• abstracts one hydrogen atom from C6 and C8 of octanoyl 
group, allowing insertion of sulfur atoms at each of these positions. It is believed that the source 
of the sulfur atom also is another iron-sulfur cluster that is bound to the protein. 
 
1.4.4 Lipoic Acid Biosynthesis pathway 
The first evidence that octanoyl domain rather than octanoyl-ACP was the substrate for sulfur 
insertion was the finding that lipB mutants grew well when supplemented with octanoic acid in 
place of lipoic acid (24). Octanoate supplementation of lipB strains required function of both the 
lipA and lplA genes. These observations argued for the existence of an LplA-dependent pathway 
that bypassed LipB function in the presence of octanoate. In the postulated bypass pathway, 
LplA would attach octanoate derived from the growth medium to the unmodified E2 domains of 
the PDH and 2-OGDH E2 subunits. LipA would then insert two sulfur atoms into the covalently 
bound octanoyl moiety and thereby convert the octanoyl-E2 domains to lipoyl-E2 domains in 
situ. E. coli strains were used with null mutations in lipA, lipB, and fadE to incorporate 
exogenous deuterated octanoic acid into a lipoyl-accepting domain on a plasmid. When lipoyl 
synthase activity was induced by transduction of the culture with phage particles containing a 
lipA cosmid, the deuterium containing octanoyl groups had become lipoylated. No lipoylated 
domains were observed in cultures that were not transduced with the lipA cosmid. The same 
conclusion was obtained from in vitro studies using purified LipA. By monitoring the cleavage 
of SAM and lipoyl-E2 formation, significant production of 5’-deoxyadenosine was observed 
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when octanoyl-E2 was the starting substrate, while only trace amounts were observed when 
octanoyl-E2 was replaced with octanoyl-ACP.  
Recently a novel pathway for the biosynthesis of lipoic acid in Bacillus subtilis has been 
reported. While lipoic acid synthesis in E. coli is accomplished by two enzymes, B. subtilis was 
found to require three enzymes. Bacillus subtilis also requires GcvH as an intermediate carrier 
whereas E. coli does not. In the newly discovered model octanoyl moieties are transferred from 
the ACP of fatty acid synthesis to the GcvH protein of the glycine cleavage system by LipM. 
The octanoyl moieties are then transferred by LipL, a novel GcvH : E2 
amidotransferase(transamidase), from GcvH to E2 subunits to form active dehydrogenase 
complexes (50).  
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1.5 Aims and scope of this dissertation 
Despite the enormous effort put into elucidating the role of lipoic acid in the multienzyme 
complexes and its role as a cofactor, studies on the mechanism by which lipoic acid is 
synthesized and attached to its cognate proteins has lagged behind. The intermediates and 
sequence of events associated with its biosynthesis has not been fully demonstrated in vivo. 
LipB was called initially a lipoyl transferase because of the first activity assays were using 
lipoyl-ACP to transfer lipoic acid to acceptor domains from pyruvate dehydrogenase. However 
LipB was subsequently found to use octanoyl-ACP as a substrate and growth of LipB mutant 
strains is supported by either lipoate or octanoate. Genetic analysis plus the demonstration that 
octanoyl domains are converted to lipoyl domains in vivo and in vitro by LipA indicates that the 
in vivo substrate for LipB is octanoyl-ACP and that lipoyl-ACP was acting as an octanoyl-ACP 
mimic. However proof for LipB predominant in vivo activity is needed. The aim of this thesis is 
to obtain a better understanding of how Lipoic acid is synthesized and incorporated into proteins 
of E. coli.  
In Chapter Two, a new coelution assay was established for studying protein-protein interactions 
in the assembly of lipoic acid on 2-oxoacid dehydrogenases of central metabolism. This chapter 
will include the identification of proteins that coelute with lipoic acid metabolism enzymes and 
genetic identification of the subunits interacting with lipoic acid enzymes. It will also include a 
section on the interaction of LipB with the E2o protein of the α-ketoglutarate dehydrogenase. In 
addition, the properties of an isolated LipB-ACP complex are reported.  
Chapter Three investigates the reaction mechanism of LipB in vivo. It will report on our efforts 
to isolate post-translationally modified peptides in LipB and the establishment of LipB in vivo 
activity. Isolation of the peptide containing the active site cysteine is reported and the instability 
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of the thioester bond after trypsin digestion is demonstrated. GC/MS of whole protein extracts 
are used to demonstrate that the major pathway of Lipoic acid biosynthesis involve an octanoyl 
transferase activity of LipB.  
Finally, Chapter Four is a summary of the work done in this thesis. 
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Figure 1.1 Chemical structures: A. octanoic acid. B. Lipoic acid and C. lysine lipoamide. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 16 
 
 
 
Figure 1.2 Reaction of the pyruvate dehydrogenase complex. The E1 subunit is a thiamine 
diphosphate dependent decarboxylase which catalyses the decarboxylation of pyruvate and the 
reductive acetylation of the lipoyl group bound the second subunit, E2. E2 is a dihydrolipoyl 
acetyl transferase which is responsible for acetyl transfer to CoA. The third subunit is a 
dihydrolipoyl dehydrogenase that serves to regenerate the lipoyl group for another round of 
catalysis. 
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Figure 1.3 The modular structure of E2 subunits of the 2-oxoacid dehydrogenases. From 
the N terminus to the C terminus: Lipoyl domains (1-3) are followed by an E1/E2 binding 
domain and then by the catalytic core domain. These domains are separated by stretches of 
polypeptide chains (25-30 residues) rich in alanine, proline and charged amino acids that form 
flexible and extended linkers. 
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Figure 1.4 Structures of biotinyl and lipoyl domains. (A) Biotinyl domain from BCCP of E. 
coli acetyl-CoA carboxylase; (B) hybrid lipoyl domain from E. coli E2p. (C) Lipoyl domain 
from E. coli E2o. (D) H-protein from glycine cleavage system of pea leaves (51). 
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Figure 1.5 Model of lipoic acid biosynthesis in E.coli. Lipoic acid is synthesized as an 
offshoot of fatty acid biosynthesis by the consecutive activities of LipB and LipA.  LipB 
transfers an octanoyl moiety from octanoyl-ACP to the ε-amino group of a specific lysine 
residue of the highly conserved lipoyl domains of the PDH, OGDH and Gcv complexes. LipA 
then inserts two sulfur atoms at position 6 and 8 of the octanoyl domains to form the functional 
enzyme complexes. Lipoic acid can be also scavenged from the environment and attached to LD 
by the lipoate protein ligase LplA.  
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Figure 1.6  The reactions of BioB and LipA. (A). conversion of dethiobiotin to biotin by 
BioB. (B). Conversion of octanoic acid to lipoic acid by LipA.  
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CHAPTER TWO: PROTEIN-PROTEIN INTERACTIONS IN ASSEMBLY OF LIPOIC 
ACID ON THE 2-OXOACID DEHYDROGENASES OF AEROBIC METABOLISM 
 
 
2.1 Introduction 
 
Lipoic acid [(R)-5-(1, 2-dithiolan-3-yl) pentanoic acid] is a sulfur-containing cofactor covalently 
attached to and essential for the function of several key enzymatic complexes of central 
metabolism. These include the pyruvate dehydrogenase (PDH), 2-oxoglutarate dehydrogenase 
(OGDH), branched-chain 2-oxoacid dehydrogenase, acetoin dehydrogenase and the glycine 
cleavage system (GCV) (1).  Escherichia coli contains only the PDH, OGDH and GCV enzyme 
complexes, the first two of which are essential for aerobic metabolism. In each of these 
enzymes, a specific component (E2 in the 2-oxoacid dehydrogenases, H protein in the glycine 
cleavage system) is modified by the covalent attachment of lipoic acid to the ε–amino group of 
a conserved lysine residue via an amide bond.  The lysine residues protrude from the surfaces of 
the highly conserved domains which are generally called lipoyl domains (LD). The LD-bound 
coenzyme shuttles reaction intermediates among the multiple active sites of these multiprotein 
complexes in a type of covalent substrate channeling (1). 
PDH catalyzes the oxidative decarboxylation of pyruvate to form acetyl-CoA (Fig. 1) (1). This 
very large enzyme complex (larger than the ribosome) consists of multiple copies of three 
components encoded by the aceEF lpd operon. The first component, E1p, encoded by aceE is a 
thiamine pyrophosphate-dependant decarboxylase that catalyzes the decarboxylation of 
pyruvate and the reductive acetylation of the lipoyl moiety of the second component, E2p. The 
E2p component (encoded by aceF) is the dihydrolipoyl acetyltransferase responsible for the 
transfer of the acetyl group from the lipoyl moiety to CoA to produce the essential metabolic 
intermediate, acetyl-CoA. The third component, E3, encoded by lpd, is the common component 
of all three lipoic acid-dependent enzymes and is the dihydrolipoyl dehydrogenase responsible 
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for oxidizing the disulfide bond of lipoate to prepare the enzyme complex for another round of 
catalysis. The OGDH complex, which is closely related to the PDH complex, catalyzes the 
decarboxylation of 2-oxoglutarate to succinyl-CoA in the citric acid cycle. It also contains three 
components: Lpd, a succinate decarboxylase component, E1o, encoded by sucA and a succinyl 
transferase component, E2o, encoded by sucB.  The third E. coli lipoylated complex is the 
glycine cleavage system, GCV, which catalyzes the reversible oxidation of glycine, yielding 
carbon dioxide, ammonia and a C1 moiety in the form of methylene tetrahydrofolate. It consists 
of Lpd plus three proteins T, H and P encoded by the gcvT gcvH gcvP operon where gcvH 
encodes the lipoic acid-modified H protein.  
In all 2-oxoacid dehydrogenase (2-OADH) complexes the E2 components constitute the inner 
core of the complexes and play vital roles in both assembly of the complexes and in substrate 
channeling (1). The E2s are highly segmented proteins composed of modular independently 
folded domains linked together by Ala-Pro rich hinge segments. The N-terminal lipoyl domains 
(1-3 domains depending on the enzyme and organism) are followed by a domain that binds the 
E1 and E3 components. The C-terminal half of the protein contains the acyltransferase catalytic 
domain with the active site residues located close to the C-terminus. The E2 components are 
organized into either octahedral or icosahedral symmetries depending on the organism (24-mer 
octahedral symmetry in gram negative bacteria; 60-mer icosahedral symmetry in gram positive 
bacteria and mitochondria). Multiple copies of the E1 and E3 components bind tightly to the E2 
core to form the outer shell of the complexes. The gap between the inner and outer shells (75 to 
90 Å) is spanned by the flexible, but extended, conformations of the linker polypeptides that 
radiate outward from the inner E2 core (1, 2). The lipoyl moiety of the lipoyl domains; together 
with the linker regions connecting the lipoyl domains make up long swinging arms that are able 
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to carry the reaction intermediates to distant E1 and E3 active sites (1). In contrast to the 2-
OADH complexes, the lipoylated H protein is a relatively small protein of 14 kDa found free in 
cell extracts (the well-characterized Gcv complexes are known to readily dissociate) (3). 
 
 
 
Fig. 2.1  The pyruvate dehydrogenase (PDH) reaction.  Pyruvate (upper left corner) is 
decarboxylated by the E1 component (AceE) in a thiamine pyrophosphate-dependent reaction 
that results in the reductive acetylation of the lipoyl group bound to an LD (designated D) of the 
second component, E2p (AceF).  The acetylated lipoyl moiety of the LD then interacts with the 
E2 catalytic site (CAT) located at the C-terminus of the component where the acetyl group is 
transferred to CoA.  Finally, the reduced LD lipoyl moiety is oxidized by the E3 component 
(LpdA) to reset the dehydrogenase for another cycle of acetyl-CoA synthesis.  The OGDH 
reaction proceeds by the same mechanism with 2-oxoglutarate in place of pyruvate and 
produces  succinyl-CoA.  However, the OGDH E2 component (SucB) contains only a single 
LD.  
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In the current model of lipoic acid biosynthesis and attachment (Fig. 2) an octanoyl moiety is 
first transferred from the octanoyl-acyl carrier protein (ACP) intermediate of fatty acid 
biosynthesis to the apoproteins by LipB (an octanoyl-ACP:protein-N-octanoyltransferase) (4). 
LipA then catalyzes sulfur insertion into positions 6 and 8 of the octanoyl moiety (4-8).  
Therefore, lipoic acid is assembled on its cognate proteins in an unusual type of biosynthetic 
pathway in which an inactive cofactor precursor is attached to the apoprotein and subsequently 
converted to the active species in a separate enzymatic step.  E. coli also has the ability to 
scavenge free lipoic acid from the medium and attach it to lipoyl domains. This process is due 
to a single ATP-dependent enzyme, LplA, the paradigm lipoate protein ligase which is also 
active with octanoate (9-11).  
We report here the unexpected finding that E. coli LipB and LipA form tight non-covalent 
interactions with the PDH and OGDH complexes, but not with GcvH, the GCV lipoylated 
protein.  In contrast, the LplA lipoate ligase showed no evidence of association with the 2-
OADH complexes. We provide genetic and biochemical evidence that LipB and LipA interact 
with the complexes through binding to the E2 components. These data indicate that the highly 
dynamic nature of the 2-OADH complexes serves not only to greatly increase the catalytic rates 
of the dehydrogenase complexes, but also facilitates the assembly of the essential cofactor 
required by the complexes to allow aerobic metabolism. We also report the isolation and 
properties of a very stable complex between LipB and ACP. 
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Fig. 2.2 The lipoic acid biosynthetic and salvage pathways. Panel A.  The mode of 
attachment of lipoic acid and the structure of the innermost lipoyl domain (LD) of the E. coli 
PDH E2 protein (AceF).  In this depiction the lipoylated lysine is at the top of the structure (the 
protruding ß-turn) and the N- and C-termini of the domain are at the bottom of the structure.  
Panel B.  The biosynthetic pathway is at the top of the figure whereas the LplA-dependent 
salvage pathway is at the bottom. Lipoic acid is synthesized as an offshoot of fatty acid 
biosynthesis by the consecutive activities of LipB and LipA.  LipB transfers an octanoyl moiety 
from octanoyl-ACP to the ε-amino group of a specific lysine residue of the highly conserved 
lipoyl domains of the PDH, OGDH and Gcv complexes. LipA then inserts two sulfur atoms at 
position 6 and 8 of the octanoyl moiety of the LipB product to form the functional enzyme 
complexes. The curved arrow is the putative pathway that would proceed by sulfur insertion 
into octanoyl-ACP (see Introduction).  Carbons 6 and 8 of the octanoyl moiety are labeled. 
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2.2 Experimental procedures 
2.2.1 Materials  –  
Anti-FLAG M2 affinity gel and monoclonal anti-HA agarose conjugate clone HA-7 were 
purchased from Sigma-Aldrich. [1-
14
C]Octanoate was purchased from American Radiolabeled 
Chemicals. The anti-lipoic acid rabbit antibody was from Calbiochem. Vivapure Maxi spin 
columns type QH were purchased from Sartorius. Tris-2-carboxyethyl phosphine hydrochloride 
was from Pierce. The oligonucleotides used for cloning and gene deletions were synthesized by 
Integrated DNA Technologies. The FLAG (DYKDDDDK) and HA (YPYDVPDYA) peptides 
were synthesized by the Carver Metabolomics Center at the University of Illinois at Urbana-
Champaign. 
 
2.2.2 Bacterial strains, growth conditions and media  – 
The bacterial strains used in this study were all derivatives of E. coli K-12. Strains KER184 and 
KER62 were described previously (12). Strain Top10 was from Invitrogen. Strain MC1061 was 
from our lab collection and used to construct gene deletions using the λred recombinase method 
(13). Cassettes encoding resistance to either kanamycin or chloramphenicol were amplified by 
PCR using plasmids pKD3 and pKD4 and electroporated into induced electrocompetant 
MC1061 cells transformed with pKD46. Using this method ∆aceE, ∆aceF, ∆aceEF and ∆lpd 
mutant strains carrying the chloramphenicol resistance cassette in place of the coding sequences 
were obtained. A strain with ∆sucAB deletion with a kanamycin resistance cassette was also 
obtained. All constructed strains were verified by PCR and by requirements for acetate and/or 
succinate for growth. Double mutant strains were obtained by P1 transduction of ∆sucAB::Kan 
allele into strain YYC186 (∆aceEF). Plasmid pCP20 was used to remove the antibiotic 
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resistance cassettes where needed.  LB and minimal medium E were the growth media routinely 
used for growth of bacterial strains. Supplements were added as necessary at the following 
concentrations: sodium acetate, 5 mM; sodium succinate, 5 mM; thiamine, 1 μg/mL; glucose 
(0.2%). Antibiotics were added at the following concentrations as necessary (in mg/L): sodium 
ampicillin, 100; chloramphenicol, 20; kanamycin sulfate, 50; spectinomycin sulfate, 100; and 
tetracycline hydrochloride, 15. 
 
2.2.3 Plasmid constructions  –  
Plasmids pYFJ31, pZX146 and pZX152 were described previously (14). Plasmids for the 
expression of C-terminal FLAG-tagged LipB was constructed by PCR amplification of the LipB 
gene from pYFJ31 using primers lipB-FLAG-fwd and lipB-FLAG-rev where the FLAG 
sequence was introduced by the reverse primer. The insert carrying LipB with the C-terminal 
FLAG octapeptide sequence was inserted into the NdeI/HindIII sites of vector pQE-2 and the 
resulting plasmid was designated as pBH101. For coexpression experiments plasmid pBH122 
was constructed by moving LipB-FLAG along with the phage T5 promoter from pBH101 into 
the PstI plus HindIII digested pBAD33 using primers B-pst1-xho1-fwd and B-Hind3-Sal1-rev. 
An N-terminal FLAG-tagged version of LipB was also inserted into the HindIII/BglII sites of 
pFLAG-MAC vector using FL-B-fwd and FL-B-rev primers (pBH141). LipA and LipA-FLAG 
were inserted into the NdeI/EcoRI sites of pET28b under the phage T7 promoter using either 
LipA-Fwd and LipA-Rev primers for the untagged version or LipA-Fwd and LipA-flag-rev 
primers for the FLAG-tagged version to give the plasmids pBH104 and pBH123, respectively. 
Plasmid pBH142 for the expression of FLAG-tagged LplA was constructed by PCR 
amplification using primers lplA-fwd and lplA-Flag-rev followed by insertion into the 
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NdeI/HindIII sites of vector pQE-2. The E2o C-terminal variants (E2o-f, E2o-II and E2o-I) 
were inserted into the NdeI/PstI sites of pQE-2 vector using a combination of primer SucB-fwd 
and the following primers SucB-rev, SucBII-rev and SucBI-rev which resulted in plasmids 
pBH146, pBH148 and pBH149, respectively. Similarly, the E2o N-terminal variant (E2o-d) was 
constructed using primers SucB-a-fwd and SucB-rev and the resulting plasmid was designated 
pBH158. The RSF1030 origin plasmid, pCY560 was constructed by John Cronan in two stages.  
First pTARA (15) was digested with NsiI plus NgoMIV and the fragment containing the gene 
encoding phage T7 RNA polymerase plus the AraC regulatory protein was ligated to plasmid 
pDLK29 (16) digested with PstI and NgoMIV to give the kanamycin resistant plasmid pCY558. 
Plasmid pCY558 was digested with NsiI (which cuts twice in the kanamycin resistant cassette) 
and ligated to the spectinomycin resistance cassette of p34S-Sm2 (17) liberated by PstI 
digestion to give the spectinomycin resistant, kanamycin sensitive plasmid pCY560. This 
plasmid expresses T7 RNA polymerase under arabinose control and the replication origin is 
compatible with those of the pBR322 and pACYC plasmid families. All constructs were 
verified by sequencing at the Carver Core DNA Sequencing Center at the University of Illinois. 
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Table 2.1 Strains and plasmids  
 
Strain or  
Plasmid 
Relevant genotype or characteristic                 Source  or   
                 reference 
Strains   
MC1061 araD139 Δ(araA-leu)7697 ΔlacX74 galK16 
galE15(GalS) λ- e14- mcrA0 relA1 rpsL150(strR) spoT1 
mcrB1 hsdR2 
Lab collection 
Top10 F
-
 mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1 araD139 Δ(ara leu) 
7697 galU galK rpsL (StrR) endA1 nupG 
Invitrogen 
KER184 rpsL lipB::Tn1000dkan (18) 
KER62 PA360 zbd-601::Tn10 (18) 
YYC186 zac::Tnl0 ΔaceEF  (19) 
SI181 ∆fadE (20) 
QC134 fabA::Cm
R
(lacZ) Q. Christensen  
ZX293 KER184/pYFJ31 (14) 
ZX297 XL1-Blue/pZX146 (14) 
ZX313 XL1-Blue/pZX152 (14) 
BH48 SI181/pYFJ31 This study 
BH55 KER184/pBH101 This study 
BH77 SI181/pBH101 This study 
BH109 MC1061 ∆aceE::CmR This study 
BH110 MC1061 ∆aceF::CmR This study 
BH111 MC1061 ∆aceEF::CmR This study 
BH112 MC1061 ∆sucAB::KanR This study 
BH114 MC1061 ∆lpd::CmR This study 
BH153 MC1061 ∆sucAB  (KanR cassette removed) This study 
BH154 MC1061 ∆aceF  (CmR cassette removed) This study 
BH155 MC1061 ∆aceEF (CmR cassette removed) This study 
BH156 MC1061 ∆lpd (CmR cassette removed) This study 
BH195 MC1061 ∆aceE (CmR cassette removed) This study 
BH229 QC134(fabA)/pBH101 This study 
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 Table 2.1 Strains and plasmids (cont.)  
BH232 KER62(serA1)/pBH101 This study 
BH235 BH153/pBH101 This study 
BH236 BH155/pBH101 This study 
BH237 BH195/pBH101 This study 
BH238 BH154/pBH101 This study 
BH239 BH156/pBH101 This study 
BH245 BH153/ pBH123+ pCY560 This study 
BH246 BH155/ pBH123+ pCY560 This study 
BH247 BH195/ pBH123+ pCY560 This study 
BH248 BH154/ pBH123+ pCY560 This study 
BH249 BH156/ pBH123+ pCY560 This study 
BH260 YYC186; ∆sucAB (KanR cassette removed) This study 
BH278 ∆sucA775::KanR  (Keio collection) (21) 
BH279 ∆sucB776::KanR  (Keio collection) (21) 
BH284 MG1655 ∆lplA::KanR  ∆LipA::CmR This study 
BH285 BH284 (Kan
R
 and Cm
R
 casettes removed) This study 
BH300 YYC186; ∆sucB::KanR This study 
BH319 YYC186; ∆sucA (KanR cassette removed) This study 
BH321 BH155/ pBH122 and pBH146 This study 
BH323 BH155/ pBH12 and pBH148 This study 
BH324 BH155/ pBH122 and pBH149 This study 
BH325 BH112/ pBH141 This study 
BH326 BH155/ pBH141 This study 
BH327 BH260/ pBH141 This study 
BH328 BH319/ pBH141 This study 
BH329 BH300/ pBH141 This study 
   
Plasmids   
pQE-2 N-terminal His-tag cloning vector Qiagen 
pET28b N-terminal His-tag cloning vector with T7 promoter Novagen 
pFLAG-MAC N-terminal Met-FLAG fusion expression vector under 
tac promoter  
Sigma 
pYFJ31 LipB(wt) cloned in pQE-2 vector (14) 
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 Table 2.1 Strains and plasmids (cont.)  
pZX146 LipB(C169S) cloned in pQE-2 vector (14) 
pZX152 LipB(C137A, C147A, C169A triple mutant) in pQE-2 (14) 
pBH101 C-terminal flagged LipB cloned in pQE-2 vector This study 
pBH104 N-terminal His-tagged LipA under T7 promoter in 
pET28b,  
This study 
pBH122 LipB-FLAG under T5 promoter in pBAD33 This study 
pBH123 LipA-FLAG in pET28b This study 
pBH141 N-terminal FLAG-LipB in pFLAG-MAC vector This study 
pBH142 LplA-FLAG in vector pQE-2  This study 
pBH144 LipB-HA tagged in vector pQE-2 This study 
pBH145 LplA-HA tagged in vector pQE-2 This study 
pBH146 E2o full length in vector pQE-2 This study 
pBH148 E2o-II construct in vector pQE-2 This study 
pBH149 E2o-I construct in vector pQE-2 This study 
pBH158 E2o-d construct in vector pQE-2 This study 
pNMN108 His-tagged E.coli GcvH-protein in pET28-a (6) 
pCY560 pTara-T7 RNA polymerase expression under arabinose 
promoter 
This study 
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Table 2.2  Oligonucleotide primers  
 
Primer Oligonucleotide sequence 
lipB-Flag-fwd CATATGTTGTATCAGGATAAAATTCTTGTCCGCCAGCTCGGTCTTCAGCCTT
ACG 
 
lipB-Flag-Rev AAGCTTTTACTTGTCGTCATCGTCCTTGTAGTCAGCGGTAATATATTCGAAG
TCCGGATTG 
 
LipA-Fwd GCGGCGTCCATATGAGTAAACCCATTGTGATGGAACGC 
LipA-Rev GCCGGAATTCTTACTTAACTTCCATCCCTTTCG 
LipA-flag-rev CGCGAATTCTTACTTGTCGTCATCGTCCTTGTAGTCCTTAACTTCCATCCCTT
TCGCCTGCAAATCGGCGTG  
 
B-pst1-xho1-
fwd 
 
GCGGCGTCCCTGCAGCTCGAGAAATCATAAAAAATTTATTTGC 
B-Hind3-Sal1-
rev 
GGACGCCGCGTCGACAAGCTTTTACTTGTCGTCATCGTCCTTG 
Fl-B-fwd 
 
GCGGCGTCAAGCTTTTGTATCAGGATAAAATTCTTGTCCGCCAGCTCGG 
 
Fl-B-rev 
 
GACGCCGCAGATCTTTAAGCGGTAATATATTCGAAGTCCGGATTGTT TAG 
 
lplA-fwd 
 
GCGGCGTCCATATGTCCACATTACGCCTGCTCATCTCTGACTCTTACGACCC
GTGG 
lplA-FL-rev 
 
GACGCCGCAAGCTTTTACTTGTCGTCATCGTCCTTGTAGTCCCTTACAGCCC
CCGCCATCCATGCCGATAACTCCCGTAGCTC  
 
LipA-HA-fwd 
 
GCGGCGTCCATATGAGTAAACCCATTGTGATGGAACGCGGTGTTAAA 
TACCG 
LipA-HA-rev 
 
CGCTACGCCTGCAGTTATGCATAGTCAGGAACGTCATAAGGATACTT 
AACTTCCATCCCTTTCGCCTGCAAATCGGCGTGGTAAGAAGAGC 
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 Table 2.2  Oligonucleotide primers (cont.) 
LipB-HA-fwd 
 
GCGGCGTCCATATGTTGTATCAGGATAAAATTCTTGTCCGCCAGCTC 
GGTCTTC 
LipB-HA-rev 
 
CGCTACGCCTGCAGTTATGCATAGTCAGGAACGTCATAAGGATAAGC 
GGTAATATATTCGAAGTCCGGATTGTTTAGTAGCGCTAAAATAT 
LplA-HA-fwd 
 
GCGGCGTCCATATGTCCACATTACGCCTGCTCATCTCTGACTCTTAC GACCC 
 
LplA-HA-rev 
 
CGCTACGCCTGCAGTTATGCATAGTCAGGAACGTCATAAGGATA 
CCTTACAGCCCCCGCCATCCATGCCGATAACTCCCGTAGCTCTTTTTC   
 
SucB-fwd GCGGCGTCCATATGAGTAGCGTAGATATTCTGGTCCCTGAC 
 
SucB-rev 
 
CGCTACGCCTGCAGCTACACGTCCAGCAGCAGACGCGTCGGATC 
 
SucBII-rev 
 
CGCTACGCCTGCAGTTAGGCGGTGGAGTTTTTCGCTTCCAGCAGACG 
SucBI-rev 
 
CGCTACGCCTGCAGTTATTGCGCCGGAGTGGACGCTTTCTCTTCAGA 
 
SucB-a-fwd GCGGCGTCCATATGTCTGAAGAGAAAGCGTCCACTCCGGCGCAAC 
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2.2.4 Coelution assays  –  
Liquid cultures (typically 50-100 ml) were inoculated into LB or glucose minimal E media 
supplemented with acetate or succinate (or both as necessary) plus the appropriate antibiotics. 
Cultures were shaken at 37ᴼC until the OD600 reached 0.6 and then isopropylthiogalactoside was 
added to 1 mM final concentration. Cultures were shaken for additional 4 h, centrifuged and the 
cell pellet washed and frozen at -80ᴼC. The cell pellets were suspended in 50 mM Tris-HCl (pH 
7.4) containing 150 mM NaCl (called TBS buffer) and lysed by addition of lysozyme to 1 
mg/ml on ice and then sonicated three times for 10 sec each. Cell lysates were centrifuged for 
30 min and the cleared lysates were incubated with 250 µl of agarose affinity gel and placed on 
a rotary mixer for 1 h of gentle mixing at 4ᴼC. The agarose affinity gel was poured into a 
column and washed with 20 column volumes of TBS and then eluted with 3 consecutive 250 µl 
washes with TBS containing 200 µg/ml of either the FLAG or HA peptides. The second and 
third eluates (which contained the bulk of the proteins) were usually analyzed on SDS-PAGE.  
 
2.2.5 In gel trypsin digestion and protein identification  – 
 The gel slices were destained and crushed in 25 mM ammonium bicarbonate buffer containing 
50% acetonitrile and dried under vacuum.  The sample was suspended in 25 µl of a 0.0125 
ng/µl trypsin solution (G-biosciences, St. Louis, MO) and subjected to digestion using a CEM 
Liberty digester (Matthew, NC) for 15 min at settings of 50 watts and 55ᴼC.  The digested 
peptides were extracted using 50% acetonitrile containing 5% formic acid, concentrated by 
evaporation under vacuum and suspended in 13 µl of 5% acetonitrile containing 0.1% formic 
acid.  Mass spectral analyses were done on 10 ml of the samples. Mass spectrometry was 
performed on a Waters Q-ToF with a Waters NanoAcquity UPLC using a linear gradient of 
 40 
 
 
acetonitrile with 0.1% formic acid from 0% to 50% in 50 min on a Waters Atlantis dC18 3 
microns particle size, 75 micron diameter x 150 mm at a flow rate of 250 nl/min.  The raw mass 
spec results were filtered using Waters ProteinLynx Global server 2.2.5 and further analyzed 
using MASCOT (Matrixsciences, Cambridge, UK), the database searches were conducted by 
Blast against the NCBI non-redundant database. 
 
2.2.6 Ion exchange and gel exclusion chromatography  –  
Ion exchange chromatography of LipB complexes was performed using a HiTrap™ Q FastFlow 
column on an AKTA purifier FPLC system in Tris-HCl buffer (pH 7.4) and a NaCl gradient to 
1M during 40 min at a 2 ml/min flow rate. Fractions corresponding to different peaks obtained 
were concentrated by ultrafiltration and analyzed by SDS-PAGE.  Gel filtration 
chromatography of LipB complexes was performed in 50 mM sodium phosphate buffer (pH 
7.0) containing 150 mM NaCl using a Superdex 75 10/300 GL column on an AKTA purifier 
FPLC system run at a 0.5 ml/min flow rate. Fractions corresponding to each peak were 
collected, concentrated and analyzed by SDS-PAGE. 
2.2.7 MALDI mass spectrometry  –  
MALDI mass spectrometry analysis of the LipB-ACP complex was accomplished by pulling 
down LipB from an ΔaceEF sucAB strain grown in rich medium supplemented with glucose, 
acetate and succinate. The column eluates were dialyzed against 2 mM ammonium acetate and 
the proteins were concentrated by ultrafiltration, mixed with sinappinic acid matrix and 
analyzed on a Voyager DE-STR MALDI mass spectrometer calibrated with enolase standards at 
2 mass points (doubly charged and singly charged species) and run in the reflection mode. 
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2.3 RESULTS 
 
 
2.3.1 High molecular weight proteins coelute with FLAG-tagged versions of LipB and LipA –  
In a series of experiments to test the specificity of LipB under physiological conditions (see 
chapter 3) we attempted to isolate the LipB acyl-enzyme intermediate formed in vivo.  To 
preserve the thioester linkage of the intermediate we used LipB species tagged with the FLAG 
epitope rather than hexahistidine-tagged LipB because the imidazole used to elute His-tagged 
proteins attacks thioesters (22).  Unexpectedly upon elution from the column with FLAG 
peptide, the column fractions were found to contain not only FLAG-tagged LipB, but also a 
consistent set of higher molecular weight proteins (Fig. 2.3 A). 
Both N-terminal and C-terminal FLAG-tagged LipB species gave this result. One of the high 
molecular weight protein bands (band B of Fig 2.3 A) had the characteristic diffuse and 
complex SDS-PAGE band pattern given by the PDH E2p protein which migrates (often in 
multiple bands) at an apparent molecular weight of  >75 kDa (E2p is a 66 kDa protein, its 
unusual migration is due to atypical SDS binding by the three lipoyl domains) (23). In order to 
test the generality of copurification of lipoic acid metabolism enzymes with high molecular 
weight proteins, over-expression plasmids encoding FLAG-tagged versions of LipA and LplA 
were constructed and the FLAG-tag protein purification repeated (Fig 2.3A).  Elution of FLAG-
LipA from the column gave a set of accompanying proteins very similar to that seen with LipB 
whereas the LplA eluates lacked higher molecular weight proteins, only LplA plus a smaller 
protein (later shown to be a LplA proteolysis product) were present. 
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Fig. 2.3 Affinity chromatography of tagged LipB, LipA and LplA and identification of 
affinity purified proteins. Panel A. SDS-PAGE analysis of fractions from FLAG affinity 
purifications of LipB, LipA and LplA and identification of the protein bands. Data obtained 
from Mascot search are displayed in terms of the mass of the identified protein, percentage of 
sequence covered and Mascot score. Panel B. Autoradiogram of an SDS-PAGE gel of affinity 
purified FLAG-LipB eluates expressed in a fadE strain grown in a medium containing [1-
14
C]octanoate. Panel C. Western blot analysis of LipB and LipA affinity purified proteins from 
aceEF and sucAB mutant strains using an anti-lipoic acid antibody. Panel D. Affinity purified 
proteins of HA-tagged LipB and LplA.  The first lane is a negative control in which no tagged 
protein was expressed.  
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2.3.2 LipB overexpression in a fadE strain -   
To test the hypothesis that the high molecular weight proteins were 2-OADH components we 
overexpressed LipB in a β-oxidation defective fadE strain (used to avoid scrambling of the 
label) in a medium containing [1-
14
C]octanoate and found that bands B and C became 
specifically labeled (Fig. 2.3 B) due to LplA-catalyzed octanoylation of the E2 component LDs 
(10).   
 
2.3.3 Western blot analysis of co-eluted proteins -  
Modification of the proteins of bands B and C was confirmed by western blotting with an anti-
lipoic acid antibody (Fig. 2.3 C).  Moreover, when the FLAG-tagged LipB and LipA proteins 
were overexpressed in a ∆aceEF host strain (the bacterial strains are given in Table 2.1) which 
lacks the PDH E1p and E2p components, the eluates lacked band B (Fig. 2.3 C).  A similar 
experiment with a ∆sucAB strain showed loss of band C (Fig. 2.3 C).   
 
2.3.4 Identification of the high molecular weight proteins – 
To identify the other proteins that coeluted with LipB, gel slices were excised from the SDS 
PAGE separations for in-gel trypsin digestion. The resulting peptides were analyzed by LC/MS 
as described in Experimental Procedures and identified by the Mascot search engine 
(www.matrixscience.com) (Fig. 2.3 A). Band A contained two proteins, the PDH E1 (pyruvate 
decarboxylase) component (E1p) encoded by the aceE gene plus the OGDH E1 component 
(E1o) encoded by the sucA gene whereas band B contained the PDH dihydrolipoamide 
acetyltransferase (E2p) component, the product of the aceF gene. The two proteins found in 
band C were identified as the dihydrolipoamide dehydrogenase E3 component encoded by the 
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lpd gene (the common component of the PDH, OGDH and the GCV complexes) and the OGDH 
dihydrolipoamide succinyltransferase component (E2o) encoded by the sucB gene (Fig. 2.3 A). 
Peptides from both LipB and ACP were found in band D indicating a LipB-ACP complex, the 
properties of which will be discussed below.  Some of the proteins identified above comigrated 
on the gels (Fig. 2.3 A) and we were unable to resolve E1o and E1p, although manipulation of 
the electrophoresis conditions allowed resolution of E2o and E3 (Fig. 2.5).   
 
2.3.5 LipB eluates have PDH and OGDH activities -  
Given that all components of both the PDH and OGDH complexes were present in LipB 
eluates, it seemed likely that the eluates would be active in the overall reactions of the PDH and 
OGDH complexes.  Indeed, this was the case.  The FLAG-LipB eluates had PDH and OGDH 
specific activities, respectively, of 50 and 21 μmole h-1 mg-1 protein in reduction of 2-
acetylpyridine adenine dinucleotide (an acetylated-NAD analogue) in the standard 2-OADH 
assay (24, 25).  
The FLAG-LipA eluates gave a very similar picture (Fig. 2.3 A) except that no band D was 
present and LipA was accompanied by a very abundant protein identified as GroEL, the large 
subunit of the GroESL chaperonin complex. Chaperonin binding can be attributed to the marked 
instability of LipA particularly under aerobic conditions where the Fe-S centers of the protein 
become oxidized (7, 26).  We expect that LipA becomes oxidized and partially unfolded upon 
cell lysis and thereby becomes a substrate of GroESL present in the extracts (the 10 kDa GroES 
subunit would migrate through the gels and be lost).  
In contrast to LipB and LipA, no high molecular weight proteins coeluted with FLAG-tagged 
LplA.  Only a low molecular weight protein migrating at an apparent MW of 20 kDa was 
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present (Fig. 2.3 A). LC-MS identified the 20 kDa band as LplA. The identified peptides 
spanned the length of the protein indicating that LplA had been cleaved in half. Proteolysis of 
LplA in crude cell extracts has previously been observed (9) and the protein is known to have a 
central region that is particularly susceptible to proteolytic cleavage (9, 27). 
A possible cross-reactivity of the FLAG antibody with a FLAG-like sequence in the E. coli 
PDH E1p protein has been reported (28).  However, under our experimental conditions PDH 
and OGDH binding required either LipB or LipA. This was shown by the finding that FLAG-
LplA showed no binding of the 2-OADH proteins (Fig. 2.3 A) and by the further 
chromatographic analyses described below.  Moreover, LipB and LplA constructs in which a 
human influenza hemagglutinin antigen (HA) tag was substituted for the FLAG tag gave results 
essentially identical to those obtained with the FLAG-tagged proteins(7) (Fig. 2.3 D). 
 
2.3.6 Further characterization of the complexes – 
Chromatography on anion exchange and gel exclusion columns were used to further 
characterize the proteins that coeluted with FLAG-LipB (Fig. 2.4).  All of the fractions 
containing LipB were combined and subjected to anion exchange chromatography. Only two 
major peaks were obtained (Fig. 2.4 A). Analysis by SDS-PAGE showed that the first peak was 
composed of LipB largely unassociated with 2-OADH complexes (lanes 1 and 2) whereas the 
second peak contained LipB associated with the PDH and OGDH complexes (lanes 3 and 4). 
Since the LipB-ACP complex also eluted in the second peak, this raised the question of whether 
or not the LipB-ACP complex was bound to the 2-OADH complexes.  To answer this question 
LipB FLAG column eluates were analyzed by size exclusion chromatography which gave three 
major peaks (Fig. 2.4 B). The first peak contained PDH complexes associated with LipB 
whereas second peak contained LipB-OGDH complexes. The third peak contained free LipB 
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plus the LipB-ACP complex showing that the LipB-ACP complex was not bound to the 2-
OADH complexes. 
 
 
 
 
 
Fig. 2.4 Anion exchange and gel filtration chromatographic separations of FLAG-LipB 
affinity purified proteins. Panel A. Anion exchange chromatography of proteins coeluted with 
FLAG-LipB on a Hitrap Q FF column as described in Experimental Procedures. Fractions that 
covered the first peak were run on SDS-PAGE in lanes 1 and 2 whereas fractions covering the 
second peak are in lanes 3 and 4. The position of the LipB-ACP complex is indicated. The lane 
marked load is the mixture of proteins applied to the column. Panel B. Gel exclusion 
chromatography of proteins coeluted with FLAG-LipB.   A Superdex 75 10/300 GL column 
was used as described in Experimental Procedures. The lane marked load is the mixture of 
proteins applied to the column.  Fractions corresponding to peaks 1, 2 and 3 were concentrated 
and analyzed by SDS-PAGE in lanes 1, 2 and 3 respectively. The position of the LipB-ACP 
complex is also indicated. The chromatogram traces in the upper panels are absorbances of the 
column effluents monitored at 280, 254 and 215 nm. 
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2.3.7 Interactions with the GCV system -  
It is noteworthy that no subunits of the glycine cleavage system were found among the proteins 
that coeluted with LipB or LipA. This was first thought to be due to the growth conditions 
which could have repressed gcv gene expression.  Hence, the experiments were repeated with 
FLAG-LipB expressed in a serA strain grown in a minimal medium with glycine as the sole 
serine source to insure that the gcv genes were induced and functional (18). However, no 
proteins other than those characterized above were observed.  Note that GcvH is reported to be 
as abundant as the E2 subunits (29). In addition, GcvH protein induced from a T7 promoter did 
not coelute with LipB when coexpressed together (Figure 2.5 A). Also in a similar fashion, 
cleared lysates containing GcvH were passed through a column having bound LplA-FLAG did 
not result in a significant coelution by FLAG peptide (Figure 2.5 A).  
 
2.3.8 Effect of LA addition on LpLA coelution –  
A plausible scenario, where the Lipoyl-AMP intermediate bound in the active site of LplA is 
needed for interaction with the complexes, was investigated. In this experiment, LplA was 
pulled down from a strain grown in the presence of excess lipoic acid. Lipoic acid would easily 
cross the membrane and bind the active site of LplA. However as seen in Figure 2.6, this does 
not promote binding to the 2-oxoacid dehydrogenases but rather reduce the LplA cleavage 
indicating that Lipoic acid promoted a more stable structure of LplA less susceptible to 
proteolysis.  
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Fig. 2.5 Coelution assays of LplA and LipB with the GcvH protein – Panel A. Coelution 
assay of GcvH protein with an LplA protein bound to the column. Cleared lysate (CL) of cells 
overexpressing GcvH were run over a column with bound LplA protein.  Panel B. Same 
coelution assay with LipB overexpressed with GcvH protein. 
 
 
 
 
 
 
 
 
 
 
 
A B 
 49 
 
 
 
Figure 2.6 LplA coelution with excess LA – Coelution of LplA in the presence of 5 mM LA is 
shown in the right two lanes where the LpLA cleavage was reduced significantly. 
 
 
 
 
 
 
 
 
 
 
 
 50 
 
 
2.3.9 Identification of the 2-OADH components responsible for binding LipA and LipB – 
In order to identify the component(s) responsible for LipB and LipA binding, we constructed E. 
coli mutant strains carrying in-frame deletions of the genes encoding the PDH (aceEF) and/or 
OGDH sucAB components as well as the E3 (lpd) component of both complexes (Table 2.1).  
Analysis of these strains confirmed the mass spectral identifications of the 2-OADH 
components, some of which were based on only a few peptides.  Both kanamycin and 
chloramphenicol resistance cassettes were used to allow facile construction of double mutant 
strains.  When necessary the resistance cassettes were removed to allow unhindered expression 
of E2p and E2o from their native promoters.  Plasmids expressing FLAG-tagged versions of 
LipB or LipA were transformed into the mutant strains (the LipA plasmid was accompanied by 
a phage T7 RNA polymerase expression plasmid). FLAG column eluates were analyzed by 8% 
SDS-PAGE under conditions where LipB and LipA migrated through the gel (Fig. 2.7).  In the 
case of the LipB eluates, deletion of sucAB resulted in clear loss of the E2o component plus loss 
of an indistinct band at the upper edge of the E1p band (Fig. 2.7A). The indistinct band was the 
E1o component as was more clearly seen in the ∆aceEF strain where the genes encoding E1p 
and E2p were deleted (Fig. 2.7A). The level of E3 protein was markedly decreased in the 
∆aceEF strain indicating that most of the E3 (Lpd) resided in the PDH complexes with the 
remainder being in OGDH complexes (Fig. 2.7A).  Deletion of aceE and lpd had no effect on 
the levels of the other proteins indicating that E1p and E3 played no roles in LipB binding (Fig. 
2.7A). This left only the E2 components as LipB binding partners.  This was tested more 
directly by individually deleting either E1p (∆aceE) or E2p (∆aceF).  Deletion of E1p resulted 
in loss of only that protein whereas deletion of E2p resulted in loss of E1p and a large decrease 
in E3. The FLAG-LipA eluates of the deletion strains gave a very similar picture (Fig. 2.7B) 
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except for the presence of GroEL as noted above.  Therefore, LipB and LipA were bound to the 
PDH complexes through the E2p component. 
We also investigated the interaction of LipB with the OGDH complex using doubly deleted 
strains (Fig. 2.7C). The FLAG-LipB eluates from a ∆aceEF ∆sucA strain contained E2o and E3 
components whereas the eluates from a ∆aceEF ∆sucB strain showed no interaction of LipB 
with the remaining OGDH components indicating that the LipB contacted the OGDH complex 
through E2o. FLAG-LipB eluates of a ∆aceEF ∆sucAB strain showed loss of all of the 2-OADH 
components providing direct evidence that LipB does not interact with the E3 component (Lpd) 
(Fig. 2.7D).  Hence, the LipB and LipA interactions mapped to the E2 components of PDH and 
OGDH and the other components were carried through the chromatographic purifications by 
their association with E2p and E2o in the native complexes. 
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Fig. 2.7 Genetic identification of the 2-OADH component(s) responsible for LipB and 
LipA binding.   Proteins coeluted with FLAG-tagged versions of LipB and LipA from ace and 
suc deletion strains are shown.  Panel A. Proteins coeluted with FLAG-LipB after 
overexpression in different host strains as indicated. Panel B. Proteins coeluted with FLAG-
LipA after overexpression in ∆ace or ∆suc strains. The last two lanes show proteins from a wild 
type that coeluted with FLAG-LipB, two column fraction are shown. Panel C. Proteins coeluted 
with FLAG-tagged LipB after overexpression in different ace suc double mutant strains. Panel 
D. Proteins coeluted with FLAG-LipB from an ∆aceEF ∆sucAB double mutant strain, the first 
lane is a wild type control. 
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2.3.10 Interaction of LipB with E2o protein fragments in vivo and in vitro –  
To delineate the E2 binding site(s), we studied E2o rather than E2p because it has a single lipoyl 
domain rather than the three present in E2p (Fig. 2.8A) and LipB rather than LipA in order to 
avoid the instability of LipA.  We constructed plasmids encoding several truncated versions of 
an N-terminally hexahistidine-tagged E2o construct called E2o-f (Fig. 2.8A).  The E2o-II 
protein lacked the catalytic core, but retained the first 200 E2o residues whereas the E2o-I 
protein lacked both the E3 binding domain and the catalytic core and thus essentially consisted 
of the lipoyl domain.  Each of these proteins could be expressed and purified (Fig. 2.8C and D).  
Several other constructs proved unstable and were discarded.  In in vivo interaction experiments 
derivatives of an ∆aceEF strain carrying compatible plasmids encoding FLAG-LipB plus E2o-f 
or a truncated E2o protein were induced and the LipB eluates were examined by SDS-PAGE 
(Fig. 2.8B).  The FLAG-LipB eluates contained a high level of E2o-f, the full length tagged E2o 
protein. Loss of the catalytic core affected the binding properties because FLAG-LipB failed to 
bind the E2o-II truncation protein and bound a significantly lower level of the E2o-I truncation 
protein. The coexpression experiments indicated that LipB bound the lipoyl domain.  However, 
the level of E2o-I protein bound was significantly less than seen with the full length E2o 
protein.  Similar results were obtained in vitro by passing purified E2o derivatives over a 
column of immobilized FLAG-LipB. In this assay FLAG-LipB purified from a ∆aceEF ∆sucAB 
strain was bound to a FLAG affinity column followed by washing with 20 column volumes of 
buffer.  E2o-f or its truncated derivitives were then passed through the columns followed by 
further washing of the columns with buffer to remove unbound proteins. The bound proteins 
were eluted with the FLAG peptide and analyzed by SDS-PAGE (Fig. 2.8E).  These data 
suggested that another binding site was present on E2o.  This was tested in vitro by construction 
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of the E2o-d protein which lacked the lipoyl domain (the first 90 residues). The His-tagged E2o-
d variant was purified from a ∆aceEF ∆sucAB strain (Fig. 2.8D) and used in binding assays 
(Fig. 2.8F). As expected from the in vivo data (Fig. 2.8B) E2o-f was strongly bound and eluted 
with LipB whereas E2o-d showed a weak binding to FLAG-LipB.  Taken together we propose 
that LipB binding to E2o involves two synergistic binding interactions: one with the lipoyl 
domain and a second with the catalytic core.  It should be noted that isolated lipoyl domains of 
70-80 residues are excellent substrates for octanoylation and subsequent sulfur insertion, both in 
vivo (4, 30, 31) and in vitro (4, 5, 14, 32) and a small octanoylated peptide has been shown to be 
a substrate for sulfur insertion in vitro (8, 33).  Moreover, the apo form of the intact PDH 
complex is a substrate for lipoate assembly both in vivo and in vitro (4, 7, 14, 34). 
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Fig. 2.8 In vivo and in vitro mapping of LipB interactions with the E2o protein. Panel A.  
Schematic of the E2o component and its C-terminal and N-terminal truncated derivatives. Panel 
B. Coexpression in vivo of FLAG-LipB with E2o-f and two truncated derivatives. The proteins 
that coeluted with FLAG-LipB were analyzed by SDS-PAGE.  Panel C. Expression of E2o 
protein and its truncation derivatives. Panel D. His-tag purifications of E2o protein and its 
truncated derivatives. Panels E and F. In vitro binding assays of FLAG-LipB to the E2o-f, E2o-
II or E2o-I proteins and E2o-f or E2o-d proteins.  The proteins that coeluted with FLAG-LipB 
were analyzed by SDS-PAGE. In the experiments of Panels E and F, FLAG-LipB from an 
aceEF sucAB background strain was applied to the column, the column was thoroughly washed 
with buffer to remove any unbound proteins and then either E2o-f or one of the truncated 
derivatives was applied to the column followed by another round of washing.  The bound 
proteins were then eluted with FLAG peptide and analyzed by SDS-PAGE. Control reactions 
for E2o-f and E2o-d run in the absence of FLAG-LipB are in two right hand lanes. 
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2.3.11 LipA and LipB independently bind the 2-OADHs –  
An attractive scenario is that LipA or LipB first binds a 2-OADH E2 component and thereby 
creates a binding site for the other enzyme.  However, this was not the case.  When FLAG-
tagged LipB was expressed in a ∆lipA host strain, the pattern and amounts of dehydrogenase 
proteins that coeluted with LipB were indistinguishable from that seen with wild type strains 
(e.g., Fig. 2.3A).  The converse experiment, expression of FLAG-LipA in a ∆lipB host strain, 
also gave a wild type result. 
 
2.3.12 Properties of the LipB-ACP complex – 
As mentioned above among the high molecular weight proteins an SDS-PAGE band that 
migrated just behind the LipB band with an apparent mass of ca. 35 kDa (Fig. 2.3A and 2.8A) 
was present. This band was present irrespective of how LipB was tagged and the band always 
migrated slower than the tagged LipB (Fig. 2.8A).   Mascot search of the band D peptides 
resulted in two hits, LipB and ACP (Fig. 2.8B).  Given these results and the fact that the SDS-
PAGE mobility of band D differed from the migration rates of both LipB and ACP, the band 
clearly was a complex of LipB and ACP. Since the molecular weight of the LipB-ACP complex 
was close to those of LipA and LplA proteins, we repeated the experiment in ∆lipA, ∆lplA and 
∆lipA lplA strains and found that the LipB-ACP complex was unaffected by these mutations 
(data not shown). For the C-terminally FLAG-tagged LipB species MALDI mass spectrometry 
gave mass values of 26,222±8 and 35,226±13 for LipB and the LipB-ACP complex, 
respectively. For the N-terminally FLAG tagged species the respective values were 25,341±5 
and 34,333±9.  Hence, the changes in LipB mass upon addition of ACP were 9003±15 and 
8,992±6, mass values close to that of decanoyl-ACP.  However, given the error in the mass 
values plus those inherent in subtraction of one large value from another we could only 
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conclude from these data that the ACP species is fully modified with its 4’-phosphopantetheinyl 
prosthetic group and the prosthetic group is probably acylated with a fatty acid of medium chain 
length. 
To test whether the LipB-ACP complex is acylated, we purified LipB from a fadE strain grown 
in a medium containing [1-
14
C]octanoate and exposed the SDS-PAGE gel to a phosphoimager 
storage screen. A faint ~35 kDa band was observed between the LipB band and the E2o band 
where the LipB-ACP complex migrates (Fig. 2.8D).  Its presence on these gels indicated that 
the LipB-ACP complex was resistant to treatment with SDS and heat in the presence of 2-
mercatoethanol. Substitution of other disulfide reducing agents, dithiothreitol (at pH 8.8) and 
tris-2-carboxyethyl phosphine, had no effect on the complex (Fig. 2.8E). Addition of an excess 
of a PDH LD to the LipB eluates had no effect on the complex indicating that it was not a 
reaction intermediate (data not shown).  However, the LipB-ACP complex was sensitive to 
treatment with 8 M urea or 6 M guanidine hydrochloride (in the absence of a reducing agent) 
prior to SDS PAGE indicating that the linkage of LipB to ACP is non-covalent (Fig. 2.8F).  
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Fig. 2.9 Properties of the LipB-ACP complex. Panel A. LipB variants with differing affinity 
tags (C-terminal FLAG, N-terminal FLAG and C-term HA) tagged versions form the complex 
as assayed by SDS-PAGE. Panel B. Mascot search results for the band migrating behind LipB 
resulted in two hits, LipB and ACP.  The peptide sequences that matched LipB and ACP are 
highlighted in red. Note that the central tryptic peptide of ACP is insoluble (35, 36) and thus 
only terminal peptides were recovered. Panel C.  MALDI-MS data for the LipB and LipB-ACP 
complex. The mass difference between LipB and LipB-ACP is also given. Panel D.  FLAG 
purification of LipB from a fadE strain grown with [1-
14
C]octanoate added to the medium.   The 
approximate position of the LipB-ACP complex is indicated. Panel E.  Resistance of the LipB-
ACP complex to reduction by different disulfide reducing agents. Panel F. Treatment of the 
LipB-ACP complex with 8 M urea or 6 M guanidine HCl (GuHCL). 
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2.4 Discussion 
An unexpected byproduct of experiments designed to study LipB function in vivo (discussed 
below) was the indication that protein-protein interactions are involved in assembly of  lipoic 
acid. LipB and LipA were found to form non-covalent interactions with the E2 components of 
PDH and OGDH that are sufficiently strong to survive chromatographic purifications.  These 
are not enzyme-substrate interactions because both the E2o and E2p components are known to 
be fully modified with lipoic acid in wild type cells (37), a finding consistent with our western 
blotting and dehydrogenase activity results  The interactions were specific in that another 
enzyme of lipoic acid metabolism, LplA, showed no interactions with either PDH or OGDH. 
Moreover, neither LipA nor LipB bound another LD protein, the H protein of the GCV system.  
The advantage of interactions of LipB and LipA with their respective substrates, the apo and 
octanoyl forms of the 2-OADH E2 components is straightforward.  Upon assembly of 
complexes from the nascent 2-OADH components, LipA and LipB would become bound and 
therefore poised to produce the protein bound lipoate molecules required for the activity of 
these key metabolic enzymes. One objection to this scenario is that the 2-OADH components 
are highly abundant proteins (ca. 5,000 molecules per cell) whereas the levels of LipA and LipB 
are below the limits of proteomic analyses (<300 molecules/cell) (29), a scarcity that precluded 
their inclusion in the E. coli global interaction network (38).  However, a LipA content of 30 
molecules per cell was recently reported based on a chromosomal fusion to yellow fluorescent 
protein (YFP) (39). (No YFP fusion data were reported for LipB, but only a fourth of the E. coli 
proteins were analyzed). Hence, the only data set that includes both the 2-OADHs and a lipoic 
acid synthetic protein is that obtained from YFP fusions. A possible caveat is that the YFP 
fusion protein values for 2-OADH protein molecules per cell are 5 to 6-fold and 2 to 3 fold 
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lower than those obtained by proteomic analysis (29) and two-dimensional gel electrophoresis 
of extracts of cells labeled with radioactive amino acids (40), respectively.  However, given that 
the same analytical method was used for both, the ratios of the YFP fusion protein numbers 
should be reliable. The YFP fusion data gave values of 843 and 850 molecules per cell for the 
PDH E1 and E2 components and a value of 158 molecules per cell for the OGDH E1 
component (39).  Assuming that the OGDH E2 component is produced at the same level as the 
cognate E1 component, then each cell roughly contains about one thousand E2 components to 
be modified by 30 molecules of LipA. These seemingly incompatible numbers are, however, 
offset by two properties of the 2-OADH complexes.  First, each complex has 24 E2 components 
in an octahedral array and therefore the 1000 E2 components are structured into about 40 
complexes, a number similar to the reported number of LipA molecules.  The second property 
of the 2-OADH complexes is that a given E2 lipoyl domain can reach far across the protein 
complex.  This latter property was demonstrated by the finding that PDH complexes can retain 
full enzymatic activity despite containing major fractions of E2 proteins that either lack lipoyl 
domains or contain lipoyl domains that cannot be modified (41).  Since, the E1 component 
catalyzes the rate-limiting step in the overall PDH reaction (41-43) it follows that the lipoyl 
domains must be able to reach distant E1 components (24 of which are in the complex). 
Moreover, the lipoyl domains of different E2 molecules are known to interact (41).  Therefore, 
it seems possible that a single molecule of a lipoic acid synthetic enzyme bound to a given E2 
component of the complex could catalyze assembly of lipoyl groups on the other E2 
components of the complex (or that LipA and LipB dissociate from a lipoylated LD and 
efficiently bind a neighboring unmodified LD due to the high localized LD concentration).  The 
high localized concentrations of LipA and LipB may be required because the proteins are not 
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only in short supply, but are also poor catalysts (6, 32) (the turnover numbers reported for LipB 
and LipA are 0.2 s
-1
 and 0.175 min
--1
, respectively, although catalytic formation of lipoate by 
LipA has yet to be demonstrated in vitro).  It should be noted that our analyses required 
overproduction of the lipoic acid metabolic proteins due to their scarcity in wild type cells. 
Overproduction undoubtedly raised the effective association constants for complex formation 
and thereby facilitated formation of the complexes.  However, once formed the complexes were 
stable in that they survived affinity chromatography as well as chromatography on ion exchange 
and size exclusion columns.   
A very stable (but noncovalent) LipB-ACP complex was also detected, the physiological 
relevance of which is unclear.  The complex seems to carry an acyl group which is probably 
octanoate, but is unable to transfer the acyl moiety to either a LD domain or to ACP and thus is 
a dead-end complex.  In prior work from this laboratory purified preparations of the [1-
14
C]octanoyl-LipB intermediate were found to transfer the octanoyl moiety either to an E2p LD 
or to ACP (14).  However, transfer was incomplete and the label that failed to transfer was 
present in a band that migrated slightly behind LipB in SDS-PAGE, a behavior similar to that 
seen for the in vivo LipB-ACP complex. Given that the in vivo complex was inactive and was 
not associated with the 2-OADHs, the LipB-ACP complex seems unlikely to have any 
physiological significance. However, its presence does provide further evidence of the link 
between the fatty acid and lipoic acid synthetic pathways.  It seems likely that the LipB-ACP 
complex is formed in vitro by a fraction of LipB molecules that adopt an aberrant off-pathway 
conformation that traps octanoyl-ACP. 
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CHAPTER THREE: LIPB IS AN OCTANOYL-[ACYL CARRIER 
PROTEIN]:PROTEIN N-OCTANOYL-TRANSFERASE IN VIVO. 
 
3.1 Introduction 
Although the functions of lipoic acid in the multienzyme complexes have been studied 
extensively, the mechanism by which lipoic acid is biosynthesized has lagged behind. Lipoic 
acid biosynthesis studies have focused on E. coli as a model system although other systems 
have also been investigated. Recently, lipoic acid biosynthesis pathway has been elucidated in 
Bacillus Subtilis  in which a two-gene requirement for the octanoyltransfer reaction has been 
discovered [1, 2].  
Octanoic acid is demonstrated to be the fatty acid precursor of lipoic acid in E. coli [3]. Using 
labeling studies of octanoic acid and analyzing conversion to lipoic acid by E. coli cells, it was 
shown that sulfur atoms are introduced with loss of only two hydrogen atoms, one from C-6 
and one from C-8 and that the reaction mechanism doesn’t involve desaturation or 
hydroxylation of octanoic acid  [4-6]. The pathway of E. coli lipoic acid biosynthesis results in 
inversion of stereochemistry at carbon 6 [5, 6] and racemization at C-8 [4, 6-8]. When lipoic 
acid is present in the medium, posttranslational modification of unlipoylated enzymes with 
scavenged lipoic acid occurs by the reaction of lipoate protein ligase (LplA). In mammals, 
covalent attachment of lipoic acid to the proteins occurs in two successive reactions. First, 
lipoic acid is activated to lipoyl-AMP by lipoate-activating enzyme [9], and then the lipoyl 
moiety is transferred to apoproteins by the action of lipoyl-AMP: N-lysine lipoyltransferase 
[10]. In E. coli, exogenous lipoate is transferred to unlipoylated enzyme by a single LplA 
protein in an ATP-dependent manner [11, 12]. This reaction is similar to that of the biotin-
protein ligase of E. coli BirA [13]. 
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LplA null mutants do not show any growth phenotype and were found to possess functional 2-
oxoacid dehydrogenases. These mutants were found to contain comparable amounts of  lipoyl-
protein content as wild type strains [11]. Thus, it was clear that an alternative protein 
lipoylation pathway existed in E.coli and it is independent from the lplA gene product. The 
second pathway in E. coli requires the lipB gene product [octanoyl(lipoyl)-ACP-protein-N-
octanoyltransferase] to transfer endogenously synthesized octanoate to apoproteins which is 
then the substrate for sulfur insertion [12, 14, 15]. This pathway does not require octanoyl or 
lipoyl additives to the medium for growth and it is called an endogenous or a de-novo 
biosynthesis pathway. 
When lipoate is not present in the medium, the endogenous pathway generates lipoylated 
enzymes by biosynthesis. Octanoyl group is first transferred from octanoyl-ACP to apo-
proteins by LipB. LipA then inserts sulfur atoms on the protein-bound octanoyl group to 
generate functional enzymes. This model explains why lplA null mutants showed no growth 
defects unless combined with lipA or lipB mutants. LplA utilizes octanoyl-ACP as substrate 
with low efficiency. Genetic and biochemical evidence demonstrated that lipB encodes the 
octanoyl-ACP:protein N-octanoyltransferase or a lipoyl-ACP:protein N-lipoyltrasnferase. His-
tagged LipB was purified and was shown to have octanoyltransferase and lipoyltransferase 
activities [14]. 
Lipoic acid synthase (LipA) is a member of the radical-SAM enzyme superfamily, which 
utilizes a reduced iron-sulfur cluster and SAM to generate a 5’-deoxyadenosyl radical (5’-dA) 
[16, 17]. Biotin synthase is another member of this superfamily involved in the last step of 
biotin biosynthesis. In each enzyme system, the role of the 5’-dA is to abstract a hydrogen 
atom initiating a radical-dependent reaction that leads to the insertion of sulfur atoms [18]. 
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Enzymes within this radical-SAM superfamily contain CXXXCXXC motifs, in which the 
conserved cysteine residues coordinate an [4Fe-4S] cluster that is required for sulfur insertions. 
The Fe-S clusters serve two functions: they act as the immediate donor of one electron, which 
is required for the reductive cleavage of SAM to generate the 5’-dA, and they also provide the 
source of sulfur atoms inserted. The remaining product of SAM cleavage is L-methionine. In 
the lipoic acid synthase reaction, the role of the 5’-dA is to remove hydrogen atoms from the 
C-6 and C-8 positions of octanoic acid, allowing for subsequent sulfur insertion [19-22]. Two 
equivalents of SAM are required to synthesize 1 equivalent of the lipoyl cofactor. The crystal 
structure of BioB has been solved and it contained a [4Fe-4S] cluster positioned to generate 5’-
dA
 
 radicals as well as a [2Fe-2S] cluster postulated to be the source of sulfur atom [23]. In 
vitro assays demonstrated that lipoic acid was formed without addition of sulfur containing 
compounds which suggested that similar to the case of biotin synthase, the lipoyl synthase has 
all the required components to carry out the catalysis reaction [20, 24]. Lipoyl synthase can 
accommodate two [4Fe-4S] clusters. One is coordinated by the CXXXCXXC motif that is 
common among radical SAM enzymes. The second cluster is coordinated in a 
CXXXXCXXXXXC motif, which is unique to lipoic acid synthase and is probably the source 
of sulfur atoms [25]. 
LipB could convert the apo form of lipoyl domain to the holo domain by using either octanoyl-
ACP or lipoyl-ACP as substrate. LipB  was found to follow Michaelis-Menten kinetics, with a 
Km for lipoyl-ACP of about 1 M [14]. The ability of purified LplA to use octanoyl-ACP or 
lipoyl-ACP as substrate was also tested in vitro. The gel mobility shift assay showed that LplA 
did indeed use lipoyl-ACP and octanoyl-ACP as substrates, although it was extremely 
inefficient. The PDH activation assay gave a Km of about 8.9 M for the reaction of LplA with 
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lipoyl-ACP, whereas the Km for the reaction of LplA with lipoate plus ATP was about 1 M. A 
nonhydrolyzable lipoyl-AMP analogue was found to competitively inhibit both ACP-
dependent and ATP-dependent reactions of LplA, suggesting that the same active site 
catalyzed two different chemical reactions [14]. It is still unclear how the active site of LplA 
copes with such different chemistries. 
In vivo and in vitro evidence that sulfur atoms can be inserted into octanoyl moieties attached 
to a PDH subunit or a hybrid lipoyl domain were reported [15]. LipB mutants in E. coli which 
require lipoate for growth were found to grow well when supplemented with octanoate in place 
of lipoate.  Octanoate supplementation of lipB mutants required both LplA and LipA.  These 
data suggested that LplA attached the octanoate moiety to the dehydrogenase subunit and LipA 
then converted the octanoate moiety to lipoic acid.  Indeed upon restoration of LipA activity, a 
conversion of the labeled octanoyl-E2 domain to lipoylated E2 domain was demonstrated by 
mass spectroscopy.  No labeled lipoyl domains were observed when LipA activity was not 
restored. Inactive octanoylated forms of the 2-oxoacid dehydrogenases that accumulated in the 
absence of LipA could be converted to the active lipoylated species upon restoration of LipA 
activity. Octanoyl-E2 domains were substrate for LipA-dependent sulfur insertion in vitro [15]. 
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Figure 3.1 The lipoic acid biosynthetic and salvage pathways. Panel A.  The mode of 
attachment of lipoic acid.  The biosynthetic pathway is at the top of the figure whereas the 
LplA-dependent salvage pathway is at the bottom. Lipoic acid is synthesized as an offshoot of 
fatty acid biosynthesis by the consecutive activities of LipB and LipA.  LipB transfers an 
octanoyl moiety from octanoyl-ACP to the ε-amino group of a specific lysine residue of the 
highly conserved lipoyl domains of the PDH, OGDH and Gcv complexes. LipA then inserts 
two sulfur atoms at position 6 and 8 of the octanoyl moiety of the LipB product to form the 
functional enzyme complexes. A putative pathway that would proceed by sulfur insertion into 
octanoyl-ACP is also shown. Panel B. cartoon for the acyl-enzyme intermediate formed by 
LipB during the LipB reaction. 
 
 
A 
B 
 72 
 
 
Evidence that an acyl-enzyme intermediate is formed during LipB reaction has been reported 
[26].  When using [
14
C]-labeled octanoyl-ACP as substrate, a signal associated with LipB 
protein was detected on SDS-PAGE gel. This suggested that an octanoyl-LipB intermediate 
was formed. LipB became octanoylated on a cysteine active site residue and the resulting 
thioester carbonyl is a target for nucleophilic attack by the lysine amino group of the E2 
subunit. This hypothesis was supported by the copurification of [
14
C-Octanoate] signal with 
LipB protein and the ability of the purified [
14
C-Oct-LipB] intermediate to catalyze tranfer of 
[
14
C-Octanoate] to an apo-E2 domain. The stability of the octanoyl-LipB intermediate together 
with the results of protein digestion and peptide mass spectrometry suggested that the 
octanoylation site might be one of the three cysteine residues (C137, C147 and C169) present 
in the LipB sequence. Sequence alignments of LipB from different sources showed that only 
one of these three cysteine (C169) residue was strictly conserved among different organisms. 
C137A, C147A, C169A and C169S mutants were constructed. C169A and C169S mutants lost 
the ability to complement lipB null mutants in vivo and showed extremely low LipB activities 
(<0.5%) in vitro. These results indicate that LipB catalyzes octanoyl transferase reaction by 
forming an acyl-enzyme intermediate and C169 is the active site residue required for acylation 
[26].  
In this chapter, I have tested a possible alternative lipoic acid assembly pathway (Figure 3.1) in 
which LipA would act on octanoyl-ACP to produce lipoyl-ACP followed by LipB-catalyzed 
transfer of the lipoyl moiety to unmodified lipoyl domains.  As described before, two in vitro 
results argued for the alternative pathway. These were the observations that LipB utilizes 
lipoyl-ACP in vitro (7,12) and that traces of S-adenosyl-L-methionine consumption in the 
presence of LipA and octanoyl-ACP. To test the alternative pathway in vivo we took advantage 
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of the finding that octanoyl transfer proceeds though an acyl enzyme intermediate in which the 
LipB active site residue Cys169 is transiently acylated . LipB was overexpressed, purified and 
the enzyme-bound acyl intermediate was investigated for its modification. 
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3.2 Materials and Methods 
Labeled octanoic acid was purchased from American
 
Radiolabeled Chemicals (St. Louis, MO). 
Trypsin, modified, sequencing grade from bovine pancreas was purchased from Roche applied 
science. The FLAG (DYKDDDDK) peptide was synthesized by the Carver Biotechnology 
Center at the University of Illinois, Urbana-Champaign. 
3.2.1 Bacterial Strains, plasmid construction and growth media - 
The bacterial strains used in this study were derivatives of E. coli K-12. Strain KER184 is 
described previously [27] whereas strains TOP10 (Invitrogen), DH5α (Invitrogen) were 
obtained commercially. Minimal medium E and L broth were the growth media routinely used 
for growth of bacterial strains. Supplements were added as necessary at the following 
concentrations: sodium acetate, 5 mM; sodium succinate, 5 mM; thiamin, 1 µg/mL; glucose 
(0.4%). Antibiotics were added at the following concentrations (in mg/L): sodium ampicillin, 
100; chloramphenicol, 20; kanamycin sulfate, 50 and tetracycline hydrochloride, 15.  
Plasmids pYFJ31, pZX146 and pZX152 were described previously [26] . Plasmid for the 
expression of C-terminal FLAG-tagged LipB was constructed by PCR amplification of the 
LipB gene from pYFJ31 using primers lipB-FLAG-fwd and lipB-FLAG-rev where the FLAG 
sequence was introduced by the reverse primer. The insert carrying LipB with the C-terminal 
FLAG octapeptide sequence was inserted into the NdeI/HindIII sites of vector pQE-2 and the 
resulting plasmid was designated as pBH101. Plasmid pBH111expressing a flag tagged LipB 
mutant in C137A and C147A was constructed exactly as pBH101 using the same primers but a 
different template [26].  A list of the strains, plasmids and primers used in included in Tables 
3.1 and 3.2. 
 
 
 75 
 
 
Table 3.1 Strains and plasmids  
 
Strain or  
Plasmid 
Relevant genotype or 
characteristic 
                Source  or   
                 reference 
Strains   
MC1061 araD139 Δ(araA-leu)7697 ΔlacX74 galK16 
galE15(GalS) λ- e14- mcrA0 relA1 rpsL150(strR) 
spoT1 mcrB1 hsdR2 
Lab collection 
Top10 F
-
 mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1 araD139 Δ(ara leu) 
7697 galU galK rpsL (StrR) endA1 nupG 
Invitrogen 
KER184 rpsL lipB::Tn1000dkan (27) 
BH168 BL21/pET28b-LipA-flag pDB1282 This study 
YYC186 zac::Tnl0 ΔaceEF  [28] 
   
ZX293 KER184/pYFJ31 [26] 
ZX297 XL1-Blue/pZX146 [26] 
ZX313 XL1-Blue/pZX152 [26] 
BH55 KER184/pBH101 This study 
BH82 Top10/pBH111 This study 
BH260 YYC186; ∆sucAB (KanR cassette removed) This study 
   
Plasmids   
pQE-2 N-terminal His-tag cloning vector Qiagen 
pET28b N-terminal His-tag cloning vector with T7 promoter Novagen 
pFLAG-MAC N-terminal Met-FLAG fusion expression vector 
under tac promoter  
Sigma 
pYFJ31 LipB(wt,  #429) cloned in pQE-2 vector [26] 
pZX146 LipB(C169S) cloned in pQE-2 vector [26] 
pZX152 LipB(C137A, C147A, C169A triple mutant) cloned 
in pQE-2 vector 
[26] 
pBH101 C-terminal flagged LipB cloned in pQE-2 vector This study 
pBH104 N-terminal His-tagged LipA under T7 promoter in 
pET28b,  
This study 
pBH111 LipB(C137A, C147A)FLAG cloned in pQE-2 
vector 
This study 
pBH122 LipB-FLAG under T5 promoter in pBAD33 This study 
pBH123 LipA-FLAG in pET28b This study 
pBH141 N-terminal FLAG-LipB in pFLAG-MAC vector This study 
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Table 3.2  Oligonucleotide primers  
 
Primer Oligonucleotide sequence 
lipB-Flag-fwd CATATGTTGTATCAGGATAAAATTCTTGTCCGCCAGCTCGGTCTTC
AGCCTTACG 
 
lipB-Flag-Rev AAGCTTTTACTTGTCGTCATCGTCCTTGTAGTCAGCGGTAATATAT
TCGAAGTCCGGATTG 
 
Fl-B-fwd 
 
GCGGCGTCAAGCTTTTGTATCAGGATAAAATTCTTGTCCGCCAGC
TCGG 
 
Fl-B-rev 
 
GACGCCGCAGATCTTTAAGCGGTAATATATTCGAAGTCCGGATTG
TT TAG 
 
LipA-Fwd GCGGCGTCCATATGAGTAAACCCATTGTGATGGAACGC 
LipA-Rev GCCGGAATTCTTACTTAACTTCCATCCCTTTCG 
LipA-FLAG-
rev 
CGCGAATTCTTACTTGTCGTCATCGTCCTTGTAGTCCTTAACTTCC
ATCCCTTTCGCCTGCAAATCGGCGTG 
 
 
3.2.2  Expression and Purification of Wild-Type and Mutant LipB Proteins –  
The LipB proteins were expressed as from the T5 promoter of vector pQE-2. The plasmids 
were introduced into strain KER184, YYC186 or BH260 and the resulting strains were 
cultured in LB broth to mid-logarithmic growth phase, and LipB overproduction was induced 
by the addition of 1.0 mM IPTG for 4 h at 37 °C. The cells were harvested by centrifugation at 
10000g for 10 min, and the pellets were stored at -80 °C until ready to use. LipB proteins were 
purified using M2 anti FLAG agarose beads according to the protocol supplied by the 
manufacturer. Frozen pellets were thawed on ice for 15 min prior to the addition of lysis buffer 
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[50 mM Tris HCl, (pH 7.4) containing 150 mM NaCl, 1 mM EDTA, and 1% Triton X-100]. 
Lysozyme (1 mg/mL) was added, and after 30 min of incubation on ice the cells were 
disrupted by sonication. The lysates were centrifuged at 13000g for 30 min, and anti-FLAG 
M2 affinity gel was added to the supernatant and rotated slowly at 4 °C for 60 min, and the 
resin was loaded into a 5 mL column and washed with abundant volumes of TBS (50 mM 
Tris-HCl, with 150 mM NaCl, pH 7.4). LipB protein was eluted with FLAG peptides in TBS at 
a concentration of 200 µg/ml. The LipB proteins purity was monitored by SDS-PAGE. 
Purified LipB fractions were pooled together, concentrated and then dialyzed against 20 mM 
sodium phosphate buffer (pH 7.0). 
 
3.2.3 Trypsin digestion and HPLC analysis -  
Trypsin, modified, sequencing grade from bovine pancreas was purchased from Roche Applied 
Science. Purified LipB The proteins to be digested are dissolved in the digestion buffer (100 
mM Tris-HCI, pH 8.5). Urea or Acetonitrile were added to the buffer prior to digestion at a 
concentration of 0.1M or 5% respectively. Trypsin is added to a ratio of enzyme to protein of 
1-50 of the protein by weight and incubated for 4h at 37° C. Samples for HPLC were acidified 
by addition of 0.1% trifluoroacetic acid and injected directly into the HPLC. Digestion 
products were seperated by reverse phase HPLC on a C18 column. The peptides were eluted 
over a linear gradient of 0-50% acetonitrile (v/v) in 0.1% (v/v) trifluoroacetic acid over 120 
min.  Peptides were recovered by SpeedVac drying and analysed by MALDI-TOF mass 
spectrometry.  
 
 
 78 
 
 
3.2.4 MALDI mass spectrometry measurements - 
MALDI mass spectrometry analysis of peptides was accomplished by collecting the fractions 
corresponding to peak absorbance at 215 nm dried under vacuum then resuspended in 50% 
acetonitrile. Samples for MALDI analysis were mixed with α-cyano-4-hydroxycinnamic acid 
matrix and analyzed on a Voyager DE-STR MALDI mass spectrometer calibrated with AI 
standards at 2 mass points (angiotensin 1297 Da and insulin 5734 Da) and run in the reflection 
mode. 
 
3.2.5 preparation of oct-ACP by the reaction of vibrio harveyi Acyl ACP Synthetase - 
Acyl-ACPs were synthesized according to the method of Shen et al [29]. The 1 mL reaction 
mixture contained 10 mM ATP, 20 mM MgSO4, 0.1 M Tris-HCl (pH 7.8), 1 mM DTT, holo-
ACP, 40 µg of His-tagged Vibrio harveyi acyl-ACP synthetase purified from E. coli and either 
0.5 mM octanoic acid or 0.19 mM [1-
14
C]octanoic acid (0.1 mCi/mL, 53 mCi/mmol). The 
reaction mixtures were incubated at 37 °C for 4 h. Two volumes of acetone were then added to 
each sample, and the mixtures were allowed to precipitate at -20 °C. 
The precipitates were pelleted at 20,000g for 20 min at 4 °C and then washed twice with 3 
volumes of acetone. The pellet was air-dried and resuspended in 20 mM Tris-HCl (pH 7.4). 
Completion of the acyl-ACP synthesis reaction was tested by gel shift assay.  
 
3.2.6 Acid hydrolysis and GC/MS of LipB extracts -  
Preparations of LipB (5-10 mg) purified as described previously  were dissolved in 6 M HCl 
and autoclaved for 2 h to completely hydrolyze the proteins.  The hydrolysates were then 
extracted with methylene chloride and these extracts were treated with trimethylsilyl 
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diazomethane and methanol to convert fatty acids to their methyl esters .  The derivatized 
samples were injected into an Agilent10091S GC-MS instrument by splitless injection (250ᴼC) 
into an HP-1MS column (30 m x 250 µm x 0.25 µm). Helium carrier gas was maintained at 
constant flow of 1.5 ml/min. The initial oven temperature was maintained at 40ᴼC for one min 
then increased to 180ᴼC at a rate of 20 deg/min. Temperature was later increased to 270ᴼC at a 
rate of 10 deg/min. The gas chromatograms were searched for the presence of methyl 
octanoate from the library or extracted for methyl lipoate ions obtained from standards . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
           
 
 80 
 
 
3.3 Results        
3.3.1 LipB Trypsin digestion and isolation of peptides containing the active site C169 residue -  
To study protein modification in vivo, we purified LipB proteins either by FLAG affinity 
chromatography or by His-tag nickel affinity chromatography followed by ion exchange 
chromatography as described before [26]. Purified LipB proteins were subjected to Trypsin 
digestion as described in materials and methods, injected directly and analyzed using a 
Beckman gold HPLC system. During the initial phase of this project, it was observed that 
addition of TCEP to trypsin digests prior to HPLC injection resulted in the increase of the 
height of one particular peak with a retention time around 56 min as compared to the one 
lacking TCEP (indicated with an arrow in figure 3.2). This strongly suggested a peptide with a 
cysteine residue with the peak at 56.3 min being the reduced form of the peptide. 
A LipB trypsin digestion profile is shown in figure 3.3 followed by a table predicting the 
tryptic peptides, their mass and their position on the chromatogram (Table 3.3).  
Mass spectra of the peptide at 56.3 min (Figure 3.4A) showed two major peaks: a 1,384.55 Da 
peptide interpreted as a reduced form and a 2,766.95 Da peptide interpreted as the oxidized 
form of the peptide: INPCGYAGMEMAK. 
This led to the identification of this peptide at 56.3 min of the HPLC chromatogram as the 
peptide containing the C169 active site cysteine. This peptide will be referred subsequently as 
the INPCG peptide which was also sequenced by LC/MS-MS and its daughter b and y ions are 
highlighted in Figure 3.4 B. 
Trypsin digestion and mass spectrometry mapped 83% of the LipB sequence. Notably absent 
were the two peptides containing the two other cysteine residues. Peptides containing an 
octanoyl or a lipoyl modification were also absent.  
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The same analysis was also repeated with a number of other LipB mutant proteins including a 
C169S in which the active site cysteine was mutated to a serine. This mutant protein was 
previously shown to accept octanoyl modification from ACP in vitro, but it was deficient in 
transfer to the lipoyl domains thus trapping the octanoyl modification in a dead end product  
[26]. The oxygen ester intermediate formed is thought to be more stable than the thioester 
intermediate formed by wild type LipB, however analysis of its trypsin peptides also failed to 
uncover any modified peptides. 
 
 
Fig 3.2 LipB trypsin digestion chromatogram in the presence and absence of TCEP. 
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Fig 3.3  HPLC chromatogram of tryptic LipB peptides – The trace in the upper panel was 
obtained by monitoring OD at 215 nm. Lower panel highlights the sequence of the LipB 
peptides identified. 
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Table 3.3 Identified peptides of LipB and their mass in Da –The position of the identified 
peptides on the HPLC chromatogram of Figure 3.3 is shown in the last column. 
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Fig 3.4 MALDI-MS spectrum of the peptide at 56.3 min - PanelA. A major peak of 1384.55 
Da for the INPCG peptide was present in the 56.3 min fraction as well as second peak of 
2766.95 Da interpreted as a peptide dimer. PanelB. LC/MS-MS of the INPCG peptide at 56.3 
min – sequencing of the peptide at 56.3 min of the HPLC chromatogram identified it as the 
unmodified INPCGYAGMEMAK peptide of LipB. 
A 
B 
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3.3.2 LipB and Oct-ACP co-digestion experiments - 
To obtain an idea of the retention time of an octanoyl-INPCG peptide and consequently 
facilitate its isolation from in-vivo preparations, I have carried out co-digestion experiments in 
which LipB and ACP preparations were digested together as follows: Cold or labeled [1-
14
C]octanoyl-ACP were prepared by the reaction of Vibrio harveyi acyl-ACP synthetase 
described in Materials and Methods. LipB and octanoyl-ACP were mixed together to allow the 
octanoyl transfer reaction to occur in the absence of any acceptor lipoyl domain. The reaction 
was allowed to proceed for 30 min at 37ᴼC to allow for a complete transfer of the octanoyl 
label to LipB after which trypsin was added and the digestion was allowed to proceed. The 
resulting peptides were injected into the HPLC coupled to an inflow radioactivity detector. 
Absorbance at 215 nm and counts from the radioflow detector were monitored simultaneously 
and plotted in Figure 3.5 with the appropriate control reactions. 
The ACP radiochromatogram consisted of three radiolabeled peaks with the major peak having 
a retention time of around 122 min. When mixed with LipB, two additional radiolabeled peaks 
appeared around 66 min and 70 min, with the majority of label at the 70 min retention time. 
The co-digestion experiments were repeated with unlabeled oct-ACP and the fractions 
corresponding to the peaks 66 and 70 min were analyzed by mass spectrometry. However no 
modified peptides were found. 
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Fig 3.5 LipB and oct-ACP codigestion experiments – Radiochromatogram from ACP 
digestion alone is highlighted. The resulting peaks that appeared as a result of LipB addition is 
highlighted in LipB+ACP radiochromatogram. The three remaining peaks coming from ACP 
peptides are also indicated. 
 
 
 
 
 
 
 
From 
ACP 
From 
ACP 
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3.3.3 Trypsin digestion of the purified [1-
14
C]octanoyl-LipB intermediate-  
To obtain a cleaner result, the above described LipB and ACP co-digestion experiments were 
repeated with some modifications: LipB-FLAG and [1-
14
C] labeled octanoyl-ACP were 
incubated as before for 30 min to allow complete octanoyl transfer. Then the transfer reaction 
was mixed with M2 anti-FLAG agarose beads at 4ᴼC and LipB was completely separated from 
ACP species left in the reaction volume. The agarose beads were poured into a column, 
washed and LipB protein was eluted with FLAG peptide.  A sample was taken before trypsin 
digestion and Figure 3.6 shows the labeling of LipB protein with [1-
14
C]-octanoate and its 
separation from ACP. Trypsin digestion was accomplished as before and the peptides were 
separated in HPLC with simultaneous monitoring of the 
14
C signal. The radiochromatogram 
that resulted from trypsin digestion of labeled LipB intermediate is shown in Figure 3.7. It 
contained one major peak with retention time around 70 min comparable to the one found 
before in the codigestion experiments. However, mass spectrometry failed again to identify an 
octanoylated peptide in this peak. 
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Fig 3.6 Labeling of LipB with octanoate and separation from ACP analyzed by HPLC – 
LipB-FLAG proteins were incubated with oct-ACP and the labeled LipB proteins were 
separated from excess ACP my FLAG affinity chromatography on M2 agarose beads then 
analyzed by HPLC and radiochromatography.   
 
Oct-LipB-flag radiochromatogram 
Oct-LipB-flag protein 215 nm 
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Fig 3.7 Trypsin digestion of the purified [1-
14
C]octanoyl-LipB intermediate – Purified 14C-
oct-LipB and Oct-LipB intermediates prepared as described in text were digested and resolved 
by HPLC. The radiochromatogram showed one major radiolabeled peak with a retention time 
around 70 min similar to that found in co-digestion experiments. 
 
 
 
 
 
 
 
LipB 
radiochromatogram 
14C-oct LipB-
intermediate 
Oct- LipB 
intermediate 
i 
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3.3.4 Instability of octanoyl-peptide after digestion –  
The failure to identify modified peptides in the region around 70 min of the chromatogram 
raised suspicion of instability of the octanoyl-INPCG peptide after digestion and that the label 
found at 70 min retention time is a cleaved octanoyl group. To test this idea, [1-
14
C]-octanoate 
standard and different digestion reactions were spotted and run on TLC plate. The plate was 
exposed to Xray film and the result is shown in Figure 3.8A. It was interesting to see that the 
label in the codigestion reaction of [1-
14
C]-oct-ACP and LipB resulted in a migration pattern 
similar to that of free octanoate. Interesting also, the co-digestion reaction with a LipB mutant 
lacking the two other cysteine residues (C137A and C147A) called LipB-AAC mutant lacked 
the band corresponding to free octanoate. This suggested that either C137 or C147 residues 
were involved in a nucleophilic attack on the octanoyl-INPCG peptide thioester bond resulting 
in octanoyl group cleavage. In addition, as shown in Figure 3.8B, a [1-
14
C]-octanoate standard 
had a retention time around 70 min using the same linear gradient and HPLC parameters as the 
one for co-digestion experiments. 
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Fig 3.8 Instability of the octanoyl-peptide during trypsin digestion –  
Panel A- Different trypsin digestions were spotted on a TLC plate along with free octanoate in 
the first lane. Panel B- Radiochromatogram for free [1-
14
C-octanoate] with a retention time of 
70 min. 
A 
B 
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3.3.5 Chemical modification of isolated peptide with Octanoyl –  
Chemical synthesis of octanoyl-INPCG peptide was carried out using a chemical synthesis 
method used in the past to make acyl-thioesters of ACP with native structures [30]. In this 
method, N,N'-carbonyldiimidazole was used to make N-octanoylimidazole according to the 
equation in Figure 3.9A. The INPCG peptide was prepared by trypsin digestion of LipB 
followed by HPLC separation, collection of the peaks and drying under vacuum.  
For the synthesis of octanoyl-INPCG peptide, the peptide was resuspended in 0.5 M 
imidazole-HCl, pH 6.5; 2 mM Na EDTA containing dithioerythritol. N-octanoylimidazole in 
dry acetonitrile was added to a final concentration of 5 mM. After 10-15 min at 22°C, 
trichloroacetic acid was added to 10%, and the reaction was injected and analysed by HPLC. 
In figure 3.9B, shown is a LipB chromatogram from which the INPCG peptide was purified, 
the retention time of N-octanoylimidazole synthesized and the transfer reaction containing 
both INPCG peptide and N-octanoylimidazole. As seen in this figure, the INPCG peptide did 
not change its retention time as a result of N-octanoylimidazole addition and thus the octanoyl 
was not transferred to the peptide suggesting an intrinsic instability of the peptidyl thioester 
bond. 
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Fig 3.9 Chemical modification of INPCG peptide with octanoate – Panel A- Synthesis of 
N-octanoyl-imidazole. Panel B- From top to bottom: LipB trypsin digestion with the position 
of the INPCG peptide indicated; synthesized N-octanoylimidazole retention time; transfer 
reaction of octanoyl to the INPCG peptide. 
 
 
 
 
 
A 
B 
 94 
 
 
3.3.6 LipB functions solely as an octanoyl transferase in vivo -  
Since the numerous attempts made to isolate the acyl-enzyme intermediate on a tryptic peptide 
were unsuccessful due to the low level of modification (presumably due to transfer back to 
ACP, the most abundant soluble protein of E. coli) plus the instability of the thioester bond 
during trypsin digestion. The ester bond of the dead end product formed when serine is 
substituted for LipB C169  was also labile under the proteolysis conditions. Consequently we 
resorted to total analysis of purified LipB by GC/MS following acid hydrolysis of the protein, 
extraction of fatty acids and their conversion to methyl esters. Extracts of the hydrolyzed wild 
type LipB preparations were found to contain low levels (<2%) of methyl octanoate whereas 
no trace of methyl lipoate was observed. Gas chromatography of extracts of the hydrolyzed 
C169S mutant protein showed higher methyl octanoate levels than those of the wild type 
protein preparations (Figure 3.10) and the mass spectrum obtained was identical to the methyl 
octanoate spectrum of the NIST library.  In agreement with the results obtained with the wild 
type enzyme we found no detectable methyl lipoate, although a low level of methyl decanoate 
(comparable to that of methyl octanoate) and significantly higher levels of sixteen and eighteen 
carbon methyl esters.  The significance of the decanoyl species is unclear although the 
Mycobacterium tuberculosis LipB is known to bind C10 fatty acids . The long chain acids can 
be attributed to phospholipids from traces of membrane fragments that were carried through 
the LipB purification procedure. 
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Fig 3.10 GC-MS chromatogram and mass spectrum of methyl octanoate extracted from 
purified LipB -  Purified LipB proteins were acidified by addition of concentrated HCl to 6 M 
final concentration then autoclaved for 2 h at 120˚C, extracted with methylene chloride, 
derivatized by addition of trimethylsilyldiazomethane plus methanol and analyzed by GC/MS. 
Panel A. Gas chromatogram obtained from the material extracted from the hydrolyzed LipB 
C169S protein with the elution positions of methyl octanoate (octanoyl-ME) and methyl 
lipoate (lipoyl-ME) indicated. Panel B. Mass spectrum of methyl octanoate obtained from 
LipB C169S (lower spectrum) compared to the methyl octanoate spectrum of the NIST library 
(upper spectrum). 
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3.3.7 Octanoyl-ACP is not a LipA substrate in-vivo - 
As noted in the introduction, clues to a possible alternative pathway for lipoic acid 
biosynthesis include elasticity in LipB substrate specificity and a low level of SAM 
consumption in the presence of reduced LipA and octanoyl-ACP. For lipoic acid to be 
synthesized using this alternative pathway, LipA needs to catalyze the insertion of sulfur atoms 
into octanoyl-ACP of fatty acid synthesis. Thus an attempt to isolate lipoyl modifications in 
vivo was carried out. In this experiment LipA was induced from a T7 promoter in a strain 
containing the plasmid pDB1282, which contains the  iscS-iscU-iscA hscB-hscA-fdx portion 
of the  isc operon from Azotobacter vinelandii under the control of an arabinose promoter (a 
gift from Drs. Dennis Dean, Virginia Tech VA). Four liters of culture were inoculated and 
growth conditions, additives and induction was carried out similar to the procedure described 
herein [19]. Cells were harvested and total ACPs were purified [31]. The ACP proteins were 
hydrolyzed and analyzed by GC/MS similar to the procedure described in materials and 
methods for LipB. Methyl lipoate ions were absent from the GC/MS chromatogram indicating 
that oct-ACP is not a substrate for LipA in vivo. 
 
Fig 3.11 GC chromatogram of ACP extracts from strain overexpressing LipA – positions 
of C14, C16 and C18 fatty acids ME are indicated as well as the retention time of methyl 
lipoate (indicated by an arrow)  
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3.4 Discussion 
 
Given the importance of the lipoic acid in central metabolism, it is not surprising that more 
than one pathway exists in order to incorporate lipoyl modifications into the enzymatic 
complexes. In the cell, very little lipoate exists as free lipoic acid; almost all of it is attached 
the lipoyl domains. As detailed in the introduction, E. coli maintain two pathways for attaching 
lipoyl group to target lysine residues. Lipoic acid that the organism obtains from the medium is 
first activated by ATP, and then transferred with concomitant release of AMP. Both steps are 
catalyzed by a lipoate-protein ligase LplA. LplA use octanoic acid as a substrate, albeit with 
reduced efficiency. The ligase pathway has been well characterized and crystal structure of E. 
coli LplA protein with its activated lipoyl-AMP intermediate is available and in complex with 
H protein [32, 33]. Alternatively, the lipoyl group can be synthesized endogenously as an 
offshoot of fatty acid biosynthesis. The details of this pathway have not been completely 
illuminated.  A significant progress has been made in identifying the major players and 
establishing activities however some loose ends remained and proof is needed. One of them is 
concerning LipB. Jordan et al reported that E. coli and mitochondria contain lipoate 
transferases that use lipoyl-acyl carrier protein as the lipoate donor [34]. They subsequently 
reported genetic and biochemical evidence demonstrating that lipB encodes the 
lipoyltransferase [14].  In the course of these experiments the ATG initiation codon commonly 
assigned to lipB genes in genomic databases was shown to produce a nonfunctional E. coli 
LipB protein, whereas initiation at an upstream TTG codon gave a stable and enzymatically 
active protein. A tagged version of the lipB-encoded protein was purified to homogeneity and 
shown to catalyze the transfer of either lipoic acid or octanoic acid from their acyl carrier 
protein thioesters to the lipoyl domain of pyruvate dehydrogenase. 
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LipB is thus an Octanoyl (Lipoyl)-[Acyl Carrier Protein]:Protein N-Octanoyltransferase. On 
the other hand, LipA is a member the radical SAM Superfamily. The minimum requirements 
for LipA-dependent lipoyl biosynthesis have been determined [20]and LipA activity has been 
established in vitro and in vivo [15, 19, 25] . Zhao et al. established in vivo and in vitro that the 
preferred substrate for LipA is octanoyl-E2 [15]. By extension of this finding, it can be 
assumed that LipB has exclusively an octanoyl transferase activity in vivo, however this has 
not been proved. The authors used strains of E. coli with null mutations in lipA, lipB, and fadE 
to incorporate exogenous deuterated octanoic acid into the lipoyl domains from PDH. They 
induced lipoyl synthase activity by transduction of the culture with phage particles containing 
a lipA cosmid. Analysis of the isolated E2 domains by mass spectroscopy revealed that the 
deuterated octanoyl groups had become lipoylated. No labeled lipoyl domains were observed 
in cultures that were not transduced with the lipA cosmid. In vitro studies using purified LipA 
also yielded the same conclusion. By monitoring the cleavage of SAM into methionine and 5’-
deoxyadenosine, a significant production of 5'-deoxyadenosine was observed when octanoyl-
E2 was the substrate used, while only trace amounts were observed when octanoyl-ACP was 
used as a substrate. As a consequence, LipA activity is firmly established in vivo in contrast to 
LipB which still needed additional proofs. 
The investigation of the real LipB in vivo substrate presented many challenges: Lipoic acid 
biosynthesis enzymes are normally expressed in the cells at a very low level (~40 molecules of 
LipA per cell- see Chapter 2) and major efforts to purify LipB proteins expressed from its 
native promoter were unsuccessful in the past. As a result, LipB proteins needed to be 
overexpressed in E.coli which reduced their level of modification extensively as seen in the 
GC/MS data where less than 2% of LipB proteins were modified. This level of modification 
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was also obtained when B. subtilis Lipoic acid enzymes were expressed in E. coli. This in 
combination with the lability of the thioester bond made it impossible to isolate modified LipB 
peptides. However, several observations could be combined together to provide evidence for 
the predominant biosynthetic pathway in E. coli. These include our observation that LipB 
accumulates an octanoyl-enzyme intermediate with no sign of a lipoyl-enzyme intermediate, 
which indicates that lipoyl-ACP is not an intermediate in lipoic acid biosynthesis.  
Our in vivo result that oct-ACP is not a substrate for LipA in conjunction with the result of 
octanoyl-domain been the preferred substrate for sulfur insertion argue strongly against the 
second pathway. 
In addition, the intricate protein-protein interactions outlined in Chapter 2 places both LipB 
and LipA in close proximity to the lipoyl domains of PDH and OGDH but only LipB was 
found in a close association with ACP with no evidence for a LipA-ACP interaction.  
Another argument against the alternative lipoic acid biosynthesis pathway has to do with the 
energetic cost that it might incur. As it has been reported before, lipoic acid biosynthesis does 
not seem to be regulated and Lipoic acid enzymes are likely to be constitutively expressed in 
contrast to biotin biosynthesis enzymes.  lipoic acid biosynthesis incurs a lower energetic cost 
to the cell than biotin biosynthesis for several reasons; one of them is that biotin biosynthesis 
involves more enzymatic steps but also it has to do with the fact that LipB uses an activated 
intermediate as octanoyl-ACP of fatty acid biosynthesis, thus the only further energetic input 
needed is that of LipA (in the form of SAM). Therefore, relative to biotin synthesis, lipoic acid 
synthesis has a low metabolic price. This would not be the case if LipA catalysed sulfur 
insertion into octanoyl-ACP in vivo as this would significantly increase the energetic cost of 
lipoic acid biosynthesis. 
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In addition, most of lipoic acid in the cell is covalently attached and the lipoic acid 
biosynthesis pathway is limited by the amount of apo-lipoyl domain available and thus, unlike 
biotin synthesis, Lipoic acid cannot be overproduced and excreted as is the case when the 
biotin operon is deregulated.  
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CHAPTER FOUR: CONCLUSIONS 
Lipoic acid, a disulfide derivative of octanoic acid, is an essential cofactor for three principal 
enzymes in E. coli: The pyruvate dehydrogenase complex (PDH), the 2-oxoglutarate 
dehydrogenase complex (2OGDH) and the glycine cleavage system( Gcv). In these enzyme 
complexes, lipoic acid is covalently attached to the ε–amino group of a conserved lysine residue 
on a specific enzyme subunit through an amide bond and acts as a swinging arm carrying 
reaction intermediates between the various active sites in the enzyme complex. Lipoic acid 
endogenous biosynthesis is dependent on the activity of two enzymes: LipA and LipB. LipA, a 
protein containing iron-sulfur clusters catalyses the insertion of two sulfur atoms at positions 6 
and 8 of the octanoyl backbone using the S-adenosyl-methionine radical chemistry. LipB is an 
octanoyl transferase because of its ability to transfer octanoyl group from ACP to domains 
derived from the PDH complexes. 
This thesis deals with our finding that high molecular weight proteins, unknown at the time, 
coeluted with flag tagged LipB. We have identified these proteins using biochemical and 
genetic methods as being the various subunits of the pyruvate dehydrogenase and the 2-
oxoglutarate dehydrogenase complexes (all subunits were present and column eluants have 
PDH and OGDH activities). We have also identified among the LipB coeluted proteins a 
complex between LipB and the acyl carrier protein (ACP). However we didn’t find any 
evidence for the glycine cleavage system even when using culture conditions where the Gcv 
operon is fully induced (Using a serine auxotroph with glycine as a source of serine) or when 
performing coexpression assays with GcvH proteins. This result could be explained by the fact 
that the lipoylated GcvH protein unlike the 2-oxoacid dehydrogenases E2 subunits is a small 
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protein and thus does not form the complex structure associated with the 2-oxoacid 
dehydrogenases (GcvH is about 14 kDa). 
We have extended our studies to include LipA and LplA and found that LipA behaved like 
LipB in its interaction with the complexes but not LplA. In addition, LipA pulled down an 
abundant protein: GroEL of the chaperonin family of molecular chaperones, but no complex of 
LipA with ACP was found. In contrast to LipB and LipA, the lipoate protein ligase LplA 
showed no interaction with the 2-oxoacid dehydrogenases.  
We have constructed a number of mutant strains and determined the minimal requirements for 
interactions. Knocking out the E1p or E3 subunits didn’t affect the binding of the E2p of the 
PDH complex. However knocking out E2p abolished E1p binding and only residual E3 was 
observed which we demonstrated that it is associated with the OGDH complex. To verify this 
we constructed (aceEF, suc) double mutant strains by transducing different suc mutations into 
an aceEF strain demonstrated to have lpd expression. We found that LipB coelutions from this 
strain did not provide any evidence for direct binding of LipB to the E3 subunit consequently 
the E3 bands observed on SDS gels came from pulling down E3 through the E2p and E2o 
subunits and not by direct interactions. 
I have also studied LipB interaction with engineered E2o proteins and found that a truncation in 
the catalytic core or the Lipoyl domain greatly reduces the binding efficiency. Thus, we 
proposed that LipB binding to the E2 subunit of the 2-OGDH involves two synergistic 
interaction one with the Lipoyl domain and one with the catalytic core. 
These data indicate that the highly dynamic nature of the 2-OADH complexes serves not only to 
greatly increase the catalytic rates of the dehydrogenase complexes, but also facilitates the 
assembly of the essential cofactor required by the complexes to allow aerobic metabolism.  
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A very stable LipB-ACP complex was also detected, the physiological relevance of which is 
unclear. Some of the properties of this mysterious LipB-ACP complex we found include: 
Resistance to SDS-PAGE conditions (SDS denaturation, heat treatment, disulfide reducing 
agents such as β-mercaptoethanol, Dithiothreitol and TCEP (tris(2-carboxyethyl)phosphine). 
Resistance to the addition of an excess of lipoyl domains indicating that the complex is not a 
reaction intermediate. Sensitivity to high concentrations of Urea and GuHCL in the absence of 
disulfide reagents indicating that the binding is a strong non-covalent interaction. MALDI mass 
spectrometry revealed a mass difference of about 9003±15 Da between flagged LipB and the 
LipB-ACP complex suggesting a decanoyl-ACP product; however this result is still 
inconclusive given the low abundance of the complex and the error rate for MALDI at this 
molecular weight. Thus the identity of the acyl adduct is still unconfirmed. Given that the in 
vivo complex was inactive and was not associated with the 2-OADHs, the LipB-ACP complex 
seems unlikely to have any physiological significance. However, its presence does provide 
direct evidence of the link between the fatty acid and lipoic acid synthetic pathways.  
In Chapter 3, I have tested a possible alternative lipoic acid assembly pathway in which LipA 
would act on octanoyl-ACP to produce lipoyl-ACP followed by LipB-catalyzed transfer of the 
lipoyl moiety to unmodified lipoyl domains.  As described before, two in vitro results argued 
for the alternative pathway. These were the observations that LipB utilizes Lipoyl-ACP in vitro 
and that traces of S-adenosyl-L-methionine consumption in the presence of LipA and octanoyl-
ACP. To test the alternative pathway in vivo we took advantage of the finding that octanoyl 
transfer proceeds though an acyl enzyme intermediate in which the LipB active site residue 
Cys169 is transiently acylated . LipB was overexpressed, purified and the enzyme-bound acyl 
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intermediate was investigated for its modification and LipB was found to function solely as an 
octanoyl transferase in vivo. 
 
 
 
 
 
 
